Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
PL 01 - Prevention, Screening, and Management of Screen-Detected Lung Cancer
- 08:15 - 09:45
- 10/16/2017
- Location: Plenary Hall (Exhibit Hall D)
- Type: Plenary Session
- Track: Radiology/Staging/Screening
- Moderators:Michael Boyer, Matthijs Oudkerk
-
+
PL 01.01 - Current Status of Smoking Cesession Program (Tobacco Control)
08:15 - 08:35 | Presenter: Carolyn Dresler
- Abstract
Loading... -
+
PL 01.02 - Major Advances in CT Screening: A Radiologist's Perspective
08:35 - 08:55 | Presenter: Claudia I Henschke | Author(s): Rowena Yip, Michael Chung, Artit Jirapatnakul, Ricardo S Avila, David F Yankelevitz
- Abstract
Loading... -
+
PL 01.03 - Changing Epidemiology in Lung Cancer
08:55 - 09:15 | Presenter: Mary Reid
- Abstract
No abstract available for this presentation
-
+
PL 01.04 - What is the Optimal Management of Screen-Detected Lung Cancers
09:15 - 09:35 | Presenter: Shun-ichi Watanabe
- Abstract
Loading... -
+
PL 01.05 - Q&A
09:35 - 09:45
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-001 - Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial
09:30 - 09:30 | Presenter: D. Ross Camidge | Author(s): M. Tiseo, Myung-Ju Ahn, Karen L Reckamp, K.H. Hansen, Sang-We Kim, Rudolf M Huber, Howard L West, H.J. Groen, Maximilian Johannes Hochmair, Natasha B Leighl, Scott N. Gettinger, Corey J Langer, Luis Paz-Ares, Egbert F Smit, E.S. Kim, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
P1.01-002 - TP53 Mutations Predict for Poor Survival in ALK Rearrangement Lung Adenocarcinoma Patients Treated with Crizotinib
09:30 - 09:30 | Presenter: Gang Chen | Author(s): W. Wang, Chunwei Xu, Y. Chen, Wu Zhuang, G. Lin, X. Chen, B. Wu, Y. Huang, Rongrong Chen, Y. Guan, X. Yi, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-004 - Hypertension With Brigatinib: Experience in ALTA, a Randomized Phase 2 Trial in Crizotinib-Refractory ALK+ NSCLC
09:30 - 09:30 | Presenter: D. Ross Camidge | Author(s): Myung-Ju Ahn, Karen L Reckamp, Howard L West, Rudolf M Huber, Corey J Langer, Lyudmila A Bazhenova, Natasha B Leighl, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
P1.01-005 - Overall Survival (OS) After Disease Progression (PD) on Brigatinib in Patients With Crizotinib-Refractory ALK+ NSCLC in ALTA
09:30 - 09:30 | Presenter: Corey J Langer | Author(s): H. Huang, W. Reichmann, S. Lustgarten, D. Kerstein, D. Ross Camidge
- Abstract
Loading... -
+
P1.01-006 - Effect of EML-Alk Fusion Variant and Fusion Abundance on the Efficacy of Crizotinib in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tang Feng Lv | Author(s): Q. Zou, Yong Song
- Abstract
Loading... -
+
P1.01-007 - ALK Testing Trends and Patterns Among Community Practices in the United States
09:30 - 09:30 | Presenter: Peter B Illei | Author(s): W. Wong, N. Wu, Laura Chu, K. Schulze, Matthew A Gubens
- Abstract
Loading... -
+
P1.01-008 - Real-World Patient Characteristics, Testing and Treatment Patterns of ALK+ NSCLC
09:30 - 09:30 | Presenter: Matthew A Gubens | Author(s): W. Wong, N. Wu, Laura Chu, K. Schulze, Peter B Illei
- Abstract
Loading... -
+
P1.01-009 - Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Jin Kang | Author(s): H. Chen, X. Zhang, Qing Zhou, H. Tu, Yi-Long Wu, Jin -Ji Yang
- Abstract
Loading... -
+
P1.01-010 - Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC
09:30 - 09:30 | Presenter: Yangsi Li | Author(s): Benyuan Jiang, Jin -Ji Yang, X. Zhang, Z. Zhang, W. Zhong, Qing Zhou, H. Tu, Z. Wang, H. Chen, C. Xu, B. Wang, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-011 - Pattern of Care and Survival of ALK Rearranged Non-Small Cell Lung Cancer in Two Australian Referral Centres
09:30 - 09:30 | Presenter: Malinda Itchins | Author(s): S. Kao, S.A. Hayes, V.M. Howell, A.J. Gill, W.A. Cooper, R. O'Connell, S. Clarke, Nick Pavlakis
- Abstract
Loading... -
+
P1.01-012 - Ceritinib in Anaplastic Lymphoma Kinase (ALK)+ NSCLC Patients Pretreated With Only Crizotinib: ASCEND-1 Subgroup Analysis
09:30 - 09:30 | Presenter: Alice Shaw | Author(s): D. Kim, Ben J Solomon, Enriqueta Felip, Gregory J Riely, Martin Schuler, Daniel SW Tan, Laura Q Chow, D. Ross Camidge, P. Urban, C. Ortmann, I. Malet, R. Mehra
- Abstract
Loading... -
+
P1.01-013 - Patient-Reported Outcomes and Safety from the Phase III ALUR Study of Alectinib vs Chemotherapy in Pre-Treated ALK+ NSCLC
09:30 - 09:30 | Presenter: Julien Mazieres | Author(s): Silvia Novello, J. De Castro, Maria Rita Migliorino, Å. Helland, Rafal Dziadziuszko, Frank Griesinger, Jürgen Wolf, A. Zeaiter, A. Cardona, B. Balas, T. Karagiannis, M. Chlistalla, V. Smoljanovic, I. Oh
- Abstract
Loading... -
+
P1.01-014 - Feasibility of Liquid Biopsy Using Plasma and Platelets for Detection of ALK Rearrangements in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Cheol-Kyu Park | Author(s): H. Park, H. Cho, J. Lim, Y. Choi, In-Jae Oh, Young-Chul Kim
- Abstract
Loading... -
+
P1.01-015 - Crizotinib in ROS1 Rearranged or MET Deregulated Non-Small-Cell Lung Cancer (NSCLC): Final Results of the METROS Trial
09:30 - 09:30 | Presenter: Lorenza Landi | Author(s): R. Chiari, C. Dazzi, M. Tiseo, A. Chella, A. Delmonte, L. Bonanno, D.L. Cortinovis, F. De Marinis, G. Minuti, R. Buosi, A. Morabito, G. Spitaleri, C. Gridelli, P. Maione, Domenico Galetta, F. Barbieri, Francesco Grossi, Silvia Novello, R. Bruno, G. Alì, A. Proietti, G. Fontanini, A.M. Joseph, Lucio Crinò, Frederico Cappuzzo
- Abstract
Loading... -
+
P1.01-016 - Next-Generation Sequencing Shows Mechanisms of Intrinsic Resistance in ALK-Positive NSCLC Patients Treated with Crizotinib
09:30 - 09:30 | Presenter: Ben J Solomon | Author(s): J. Soria, Fiona Blackhall, Alice Shaw, D. Ross Camidge, D. Kim, Tony SK Mok, J. Fernandez-Banet, Z. Kan, S. Li, Y. Liu, S.N. Ho
- Abstract
Loading... -
+
P1.01-017 - ALK-Rearranged May Promote VTE by Increasing the Expression of TF in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Qiming Wang | Author(s): Y. Sen, H. Tang
- Abstract
Loading... -
+
P1.01-018 - Acquired Resistance to Crizotinib in Advanced NSCLC with De Novo MET Overexpression
09:30 - 09:30 | Presenter: Anna Li | Author(s): Jin -Ji Yang, X.C. Zhang, J. Su, Qing Zhou, H. Chen, Z. Xie, H. Tu, W. Zhong, Z. Wang, C. Xu, Z. Chen, H. Yan, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-019 - ALK+ Non-Small Cell Lung Cancer Treated with First Line Crizotinib: Patient Characteristics, Treatment Patterns, and Survival
09:30 - 09:30 | Presenter: Claudio Martín | Author(s): Andrés F. Cardona, Oscar Arrieta, O. Castillo-Fernandez, G. Oblitas, L. Corrales, L. Lupinacci, M.A. Pérez, L. Rojas, L. González, L. Chirinos, C. Ortíz, M. Lema, C. Vargas, C. Puparelli, H. Carranza, J. Otero, L. Ramirez-Tirado
- Abstract
Loading... -
+
P1.01-020 - Translocation ALK/EML4+ in Non-Squamous NSCLC Population and Crizotinib: What Can We Tell?
09:30 - 09:30 | Presenter: Ana Barroso | Author(s): N.C. Pereira, M. Dias, D. Coutinho, J. Pimenta, S. Campaínha, S. Conde
- Abstract
Loading... -
+
P1.01-021 - FISH and IHC Discordance in ALK Rearranged Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Akhil Kapoor | Author(s): V. Noronha, A. Joshi, Vijay Patil, R. Kaushal, A. Mahajan, A. Janu, K. Prabhash
- Abstract
Loading... -
+
P1.01-022 - Prediction of Central Nervous System Progression During Crizotinib Treatment in ALK+ NSCLC Among Hispanics
09:30 - 09:30 | Presenter: Andrés F. Cardona | Author(s): A. Ruiz Patino, Claudio Martin, Oscar Arrieta, O. Castillo-Fernandez, G. Oblitas, L. Corrales, L. Lupinacci, M.A. Pérez, L. Rojas, L. González, L. Chirinos, C. Ortiz, M. Lema, C. Vargas, C. Puparelli, H. Carranza, J. Otero, Z.L. Zatarain-Barron
- Abstract
Loading... -
+
P1.01-023 - ALK-Positive NSCLC: A TMH Experience
09:30 - 09:30 | Presenter: Vikas Talreja | Author(s): V. Noronha, A. Joshi, Vijay Patil, Alok Goel, Akhil Kapoor, R. Kumar, A. Janu, A. Mahajan, K. Prabhash
- Abstract
Loading... -
+
P1.01-024 - Plasma Circulating cfDNA as a Potential Biomarker in Clinical Management of NSCLC: Experience of Tata Memorial Hospital, India
09:30 - 09:30 | Presenter: Anuradha Choughule | Author(s): K. Prabhash, V. Naronha, Vijay Patil, A. Joshi, V. Hariniv, R. Prasad
- Abstract
Loading... -
+
P1.01-025 - Biomarker Testing in Advanced NSCLC: A Simulation-Based Assessment of Medical Oncologists
09:30 - 09:30 | Presenter: Tara Herrmann | Author(s): E. Hamarstrom, P. Fidias
- Abstract
Loading... -
+
P1.01-026 - Circulating miR-206 in Advanced Stage Lung Cancer Patients and Its Association with Cancer Cachexia
09:30 - 09:30 | Presenter: Noorwati Sutandyo | Author(s): R. Hariani, P.E. Wuyung, A. Mulawarman, R. Ramli, A. Rahmadi
- Abstract
Loading... -
+
P1.01-027 - Combination of Biomarker and Clinicopathologic Characters May Circle out Beneficiaries through Second-Line Immunotherapy: A Meta Analyse
09:30 - 09:30 | Presenter: Si-Yang Liu | Author(s): Z. Dong, C. Zhang, W. Zhong, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-028 - Characteristics of Cell Free DNA in Lung Cancer Patients
09:30 - 09:30 | Presenter: Tomonori Abe | Author(s): C. Nakashima, A. Sato, E. Sueoka, S. Kimura, N. Sueoka-Aragane
- Abstract
Loading... -
+
P1.01-029 - Lymphocyte Monocyte Ratio as a Prognostic Factor in Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tarkan Yetisyigit | Author(s): S. Seber
- Abstract
Loading... -
+
P1.01-030 - Predictive Biomarkers in Non-SmallCell Carcinoma and Their Clinical Association
09:30 - 09:30 | Presenter: Anurag Mehta
- Abstract
Loading... -
+
P1.01-031 - Utilization and Timing of Foundation Medicine (FMI) Testing in U.S. Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
09:30 - 09:30 | Presenter: Lisa Wang | Author(s): D. Page, A. Shewade, P. Lambert, B. Arnieri, W. Capra, M. Khorshid, T.I. Mughal, L. Gay, S. Foser
- Abstract
Loading... -
+
P1.01-032 - Detection of EGFR, ALK and Other Driver Oncogenes from Plasma cfDNA by Single Molecule Amplification and Re-sequencing Technology (cSMART)
09:30 - 09:30 | Presenter: Tony SK Mok | Author(s): Shun Lu, Ying Cheng, Jie Wang, Y. Wang, T. Wang, T. Yung, X. Su, F. Sun, L.T. Wang, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-033 - Thrombogenic Biomarkers in Patients with NSCLC – Associations with Thrombosis, Progression, and Survival
09:30 - 09:30 | Presenter: Marliese Alexander | Author(s): David L Ball, Ben J Solomon, M.P. Macmanus, R. Manser, B. Riedel, D. Westerman, S.M. Evans, R. Wolfe, K. Burbury
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-036 - Identifying and Addressing Gaps in Molecular Testing for Patients with Lung Cancer
09:30 - 09:30 | Presenter: Jennifer C King | Author(s): A. Ciupek, T. Perloff, A. Blanchard, K. Mason, E. Blais, D. Halverson, J. Bender, S. Madhavan, E. Petricoin
- Abstract
Loading... -
+
P1.01-037 - Circulating Tumor DNA Clearance During Treatment Associates with Improved Progression-Free Survival
09:30 - 09:30 | Presenter: Shun Lu | Author(s): Yong Song, Z. Xie, Z. Zhu, Li Liu, Min Li, X. Dong, M. Jin, Jie Hu, C. Rao, G. Tong, D. Zheng, W. Zhao, Y. Chen, H. Han-Zhang, H. Xu, X. Mao, L. Zhang, H. Liu, J. Ye
- Abstract
Loading... -
+
P1.01-038 - Identification and Characterization of Circulating Tumor Cells from Lung Cancer Patients for Selecting Target Anticancer Drugs for Relapse
09:30 - 09:30 | Presenter: Bong-Seog Kim
- Abstract
Loading... -
+
P1.01-039 - Survival Impact of Next-Generation Sequencing in Lung Cancer
09:30 - 09:30 | Presenter: Smadar Geva | Author(s): A. Belilovski Rozenblum, M. Ilouze, L.C. Roisman, Elizabeth Dudnik, A. Zer, Nir Peled
- Abstract
Loading... -
+
P1.01-040 - Clinical Utility of Plasma-Based NGS for Advanced-Stage NSCLC Patients with Insufficient or Unavailable Tumor Tissue
09:30 - 09:30 | Presenter: Pilar Garrido | Author(s): J. Zugazagoitia, A. Gómez Rueda, S. Ponce, I. Ramos, C. Camps, D. Isla, Ó. Juan, Rosario García Campelo, J. De Castro, M. Trigo, E. Jantus-Lewintre, M. Palka, Luis Paz-Ares
- Abstract
Loading... -
+
P1.01-041 - Role of Re-Biopsy During Disease Progression Non-Small Cell Lung Cancer for Acquired Resistance Analysis and Directing Oncology Treatments
09:30 - 09:30 | Presenter: Masatoshi Kakihana | Author(s): J. Maeda, J. Matsubayashi, S. Maehara, M. Hagiwara, T. Okano, Naohiro Kajiwara, T. Ohira, T. Nagao, Norihiko Ikeda
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-043 - Molecular Testing for Non-Small Cell Lung Cancer in Latin American
09:30 - 09:30 | Presenter: Ana Caroline Zimmer Gelatti | Author(s): J. Cé Coelho, F.Z. Caorsi, Clarissa Mathias, G. Werutsky
- Abstract
Loading... -
+
P1.01-044 - Detection of Circulating Tumor Cells Is Associated with Disease Burden in Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kostas Syrigos | Author(s): O. Fiste, D. Grapsa, E. Politaki, I. Stoupis, D. Mavroudis, S. Agelaki
- Abstract
Loading... -
+
P1.01-045 - Companion Diagnostic Tests for EGFR, ALK and ROS-1 vs NGS in Advanced NSCLC Patients - Which Is the Best in Terms of Cost and Effective?
09:30 - 09:30 | Presenter: Luciene Schluckebier | Author(s): R. Caetano, V. Aran, O.U. Garay, C.G. Ferreira
- Abstract
Loading... -
+
P1.01-046 - The Feasibility of Osimertinib Treatment on Brain Metastases in NSCLC Patients After 1st Generation EGFR-TKI Resistance: A Preliminary Study
09:30 - 09:30 | Presenter: Lucheng Zhu | Author(s): Shirong Zhang, B. Xia, Xueqin Chen, Shenglin Ma
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-048 - Clinical Impact of EGFR Mutation on Brain Metastasis in NSCLC Patients: A Meta-Regression Analysis
09:30 - 09:30 | Presenter: Chien-Chung Lin | Author(s): S. Yang, Yi-Lin Wu, Wei-Yuan Chang, P. Su, X. Liao, W. Su
- Abstract
Loading... -
+
P1.01-049 - Conformity of EGFR Mutation Status Between Blood Plasma and Tumor Tissue Samples Among NSCLC Adenocarcinoma Patients, at Dr. H. A. Rotinsulu Lung Hospital. A Preliminary Study
09:30 - 09:30 | Presenter: Reza Kurniawan Tanuwihardja | Author(s): H. Roesmargono
- Abstract
Loading... -
+
P1.01-050 - Cost-Effectiveness of PDL1 Based Test-And-Treat Strategy with Pembrolizumab as the 1st Line Treatment for NSCLC in Hong Kong
09:30 - 09:30 | Presenter: Herbert H Loong | Author(s): M. Huang, C.K.H. Wong, L.K.S. Leung, T. Burke, S. Chandwani, A.Y.Y. Law, S.C. Tan
- Abstract
Loading... -
+
P1.01-051 - Nivolumab Versus Chemotherapy as Post-Platinum Therapy for Advanced Non-Small Cell Lung Cancer in a Real-world Setting
09:30 - 09:30 | Presenter: Edward Brian Garon | Author(s): M. Moezi, J. Chandler, D. Waterhouse, S. Wilks, D. Richards, M. Hussein, David R Spigel, V. Gunuganti, M.D. Danese, M. Gleeson, D. Lubeck, V. Burns, B. Korytowsky, C. Batenchuk, R. Jotte
- Abstract
Loading... -
+
P1.01-052 - Patient-Reported Outcomes (PROs) in OAK: A Phase III Study of Atezolizumab vs Docetaxel in Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: M. Ballinger | Author(s): Rodolfo Bordoni, F. Ciardiello, J. Von Pawel, D. Cortinovis, P. He, T. Karagiannis, A. Sandler, W. Yu, F. Felizzi, A. Rittmeyer
- Abstract
Loading... -
+
P1.01-053 - Italian Nivolumab Expanded Access Programme (EAP): Data from Patients with Advanced Non-Squamous NSCLC and Brain Metastases
09:30 - 09:30 | Presenter: Lucio Crinò | Author(s): P. Bidoli, P. Ulivi, E. Minenza, Enrico Cortesi, Marina Chiara Garassino, Frederico Cappuzzo, Francesco Grossi, G. Tonini, M.G. Sarobba, G. Pinotti, G. Numico, R. Samaritani, L. Ciuffreda, A. Frassoldati, M.B. Bregni, A. Santo, F. Piantedosi, A. Illiano, F. De Marinis, A. Delmonte
- Abstract
Loading... -
+
P1.01-054 - PD-L1 Expression in Patients with Non-Small Cell Lung Cancer According to Underlying Pulmonary Disease: A Retrospective Study
09:30 - 09:30 | Presenter: Sayaka Ohara | Author(s): A. Saihara, Y. Matsumoto, R. Furukawa, Yuri Taniguchi, A. Sato, M. Hojo, K. Usui
- Abstract
Loading... -
+
P1.01-055 - Spectrum of Early Progression in Advanced NSCLC Patients Treated with PD-1 Inhibitors: Identifying Markers for Poor Outcome
09:30 - 09:30 | Presenter: Mizuki Nishino | Author(s): A.E. Adeni, C.A. Lydon, H. Hatabu, Pasi A Jänne, F..S. Hodi, M.M. Awad
- Abstract
Loading... -
+
P1.01-056 - Quality of Life and Clinical Outcomes of Nivolumab as 2+ Line Treatment in Advanced Refractory NSCLC Pts: Interim Analysis
09:30 - 09:30 | Presenter: Tatiana I Ionova | Author(s): A.L. Arzumanyan, L.V. Bolotina, V.V. Breder, N.N. Buevich, A.S. Danilova, E.A. Filippova, A.L. Kornietskaya, M.M. Kramchaninov, E.K. Kushniruk, D.H. Latipova, D.A. Lipatova, O.A. Malova, F.V. Moiseenko, T.P. Nikitina, S.V. Orlov, R.V. Orlova, S.A. Protsenko, K.A. Sarantseva, D.L. Stroyakovsky, A.V. Zinkovskaya, K.K. Laktionov
- Abstract
Loading... -
+
P1.01-057 - Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: José Miguel Sánchez-Torres | Author(s): J. Rogado, V. Pacheco-Barcia, M.D. Fenor De La Maza, J.M. Serra, P. Toquero, B. Vera, B. Obispo, R. Mondéjar, A. Ballesteros, O. Donnay, R. Colomer
- Abstract
Loading... -
+
P1.01-058 - Real World Data with Nivolumab: Experience in Argentina
09:30 - 09:30 | Presenter: Claudio Martin | Author(s): L. Lupinacci, F. Perazzo, C. Bas, O. Carranza, C. Puparelli, R. Kowalyzyn, I. Magri, M. Varela, Eduardo Richardet, K. Vera, S. Foglia, I. Jerez, E. Aman, G. Martinengo, E. Batagel, A. Dri, Norma Pilnik, M. Roa, P. Mando, F. Tsou, G. Recondo, F. Cayol, F. Marcos, S. Sena, C. Bagnes, Jose Nicolas Minatta, M. Rizzo
- Abstract
Loading... -
+
P1.01-059 - Combination Pembrolizumab and Low Dose Weekly Carboplatin/Paclitaxel for Patients with Recurrent/Metastatic NSCLC and PS of 2
09:30 - 09:30 | Presenter: Tamjeed Ahmed | Author(s): P. Triozzi, S. Addo, M. Kooski, W. Petty, J. Ruiz, S.C. Grant, R. D'Agostino, M. Bonomi
- Abstract
Loading... -
+
P1.01-060 - Nivolumab after Progression to Platinum- Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Mariana López Flores | Author(s): P. Diz Taín, I. Delgado Sillero, L. Sánchez Cousido, A. López González, M. Pedraza Lorenzo, Á. Rodríguez Sánchez, C. Castañón López, B. Nieto Mangudo, F. García Casabal, L. De Sande González, A. García Palomo
- Abstract
Loading... -
+
P1.01-061 - The Efficacy and Safety of Anti-PD-1 in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Systematic Review
09:30 - 09:30 | Presenter: Mingyi Di
- Abstract
Loading... -
+
P1.01-062 - KRAS Mutations (KRAS-Mut) and antiPD1/PDL1 Therapy in a Cohort of Lung Cancer (LC) Patients (P). Experience from a Single Institution
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): T. Morán, L. Vila, I. Teruel, C. Erasun, L. Angelats, S. España, C. Marc, N. Garcia-Balaña, J.M. Velarde
- Abstract
Loading... -
+
P1.01-063 - Are the Real World Patients with Advanced Non-Small Cell Lung Cancer Represented in Phase III Immunotherapy Trials?
09:30 - 09:30 | Presenter: Ana Caroline Zimmer Gelatti | Author(s): J. Cé Coelho, T. Rebelato, R. D'Avila, G. Geib, P.E. Rubini Liedke, R. Peres Pereira, G. Werutsky, S. Jobim De Azevedo
- Abstract
Loading... -
+
P1.01-064 - Efficacy and Tolerability of Nivolumab in Elderly Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kohei Yamane | Author(s): K. Takeda, M. Yanai, N. Tanaka, H. Izumi, Tomohiro Sakamoto, K. Yamaguchi, A. Yamasaki, T. Igishi, S. Eiji
- Abstract
Loading... -
+
P1.01-065 - Treatment Beyond Progression with Nivolumab in Patients with Advanced Non-Squamous NSCLC: Results from the Italian Expanded Access Program
09:30 - 09:30 | Presenter: Enrico Cortesi | Author(s): Francesco Grossi, R. Chiari, G. Azzarello, R. Berardi, D. Tassinari, G. Palmiotti, C. Verusio, A. Ardizzoia, L. Fioretto, L. Livi, S. Giusti, A. Bearz, G.L. Ceresoli, F. Piantedosi, A. Frassoldati, E. Ricevuto, G. Fasola, P. Marchetti, G. Puppo
- Abstract
Loading... -
+
P1.01-066 - PDL-1 Expression of Tumor Cell, Macrophage, and Immune Cells on Pleural Effusion
09:30 - 09:30 | Presenter: Yen-Han Tseng | Author(s): C. Lai, Y. Tseng, Teh-Ying Chou, Y. Chen
- Abstract
Loading... -
+
P1.01-067 - Characteristics and Survival Rate of Non-Small Cell Lung Cancer in Patients 45 Years of Age or Younger
09:30 - 09:30 | Presenter: Noorwati Sutandyo | Author(s): E. Soeratman, A. Mulawarman, L. Sari
- Abstract
Loading... -
+
P1.01-068 - Impact of Case-Based CME on Physician Performance in the Diagnosis and Management of NSCLC
09:30 - 09:30 | Presenter: Elaine Hamarstrom | Author(s): Tara Herrmann, Jeffrey Crawford
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-070 - BIW-8962, an Anti-GM2 Ganglioside Monoclonal Antibody, in Advanced/Recurrent Lung Cancer: A Phase I/II Study
09:30 - 09:30 | Presenter: Joo-Hang Kim | Author(s): J. Lee, Sang-We Kim, Jin-Hyoung Kang, Dae Ho Lee, Byoung Chul Cho, N. Shiraishi, V. Strout, Keunchil Park
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-072 - Epithelial-To-Mesenchymal Transition (EMT) in Lung Cancer: Classic Reproduction
09:30 - 09:30 | Presenter: Huibin Liu | Author(s): M. Zhang, J. Han, J. Song, W. Qiao
- Abstract
Loading... -
+
P1.01-073 - Over-Expression of GGPPs Contributes to Tumor Metastasis and Correlates with Poor Prognosis of Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yong Song | Author(s): Tang Feng Lv, X. Wang, W. Xu
- Abstract
Loading... -
+
P1.01-074 - Exosomal RNA-Profiling of Lung Pleural Effusions Identifies Adenocarcinoma Patients through Elevated miR-200 Expression
09:30 - 09:30 | Presenter: Per Hydbring | Author(s): L. De Petris, E. Branden, H. Koyi, M. Novak, L. Kanter, P. Hååg, J. Hurley, V. Tadigotla, J. Skog, K. Viktorsson, Simon Ekman, R. Lewensohn
- Abstract
Loading... -
+
P1.01-075 - Simultaneous Multiplex Profiling of Gene Fusions, METe14 Mutations and Immune Genes in Advanced NSCLC by NCounter Technology
09:30 - 09:30 | Presenter: Noemi Reguart | Author(s): Cristina Teixidó, A. Giménez-Capitán, N. Vilariño, A. Arcocha, P. Jares, S. Castillo, X. Bernal, S. Muñoz, Ramon Palmero, I. Sullivan, M. Marginet, N. Viñolas, D. Martinez, N. Baixeras, Miguel-Angel Molina-Vila, A. Prat
- Abstract
Loading... -
+
P1.01-076 - Comparison of PANA Mutyper and PNA Clamping for Detecting KRAS Mutations in Tumor Tissue, Cell Block and Pleural Effusion from Cancer
09:30 - 09:30 | Presenter: Chan Kwon Park | Author(s): Seung Joon Kim, Y.K. Kim
- Abstract
Loading... -
+
P1.01-077 - Oncogenic Potential of a Novel HER2 755PL In-Frame (HER2PL) Mutation in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Anya Maan-Yuh Lin | Author(s): C. Yang, J. Lin, James Chih-Hsin Yang, H. Wang
- Abstract
Loading... -
+
P1.01-078 - Longitudinal Studies of Quality of Life in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Target Therapy
09:30 - 09:30 | Presenter: Lin Zhi Xuan | Author(s): J. Chern, S. Chang, H. Wen-Tsung
- Abstract
Loading... -
+
- Abstract
No abstract available for this presentation
-
+
P1.01-078b - Dose-Paiting Radiation with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Junchao Wang | Author(s): Q. Wang, T. Li
- Abstract
Loading...
-
+
P1.02 - Biology/Pathology
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P1.02-001 - SLFN11 Expression in Early Stage Non-Small Cell Lung Cancer Predicts Benefit from Adjuvant Chemotherapy with Taxane and Platinum
09:30 - 09:30 | Presenter: Vamsidhar Velcheti | Author(s): S. Schwartz, F. Cecchi, Y. Tian, S. Sellappan, Charles M Rudin, John Poirier, T. Hembrough
- Abstract
Loading... -
+
P1.02-002 - Diagnostic Utility of MUC4 Expression to Differentiate Epithelioid Mesothelioma from Lung Adenocarcinoma and Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Vishwa Jeet Amatya | Author(s): A.S. Mawas, Kei Kushitani, Y. Kai, Y. Miyata, Morihito Okada, Y. Takeshima
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-004 - Long Non-Coding RNA XLOC_000090 Promotes Lung Cancer Migration Through Modulation of miR-4505
09:30 - 09:30 | Presenter: Bin Zhang | Author(s): H. Zhang, L. Gao, Dongsheng Yue, Z. Zhang, Chenguang Li, C. Wang
- Abstract
Loading... -
+
P1.02-005 - Solving the Interfering Problem of Tissue Embedding OCT Compound in Activity Based Multiplex Profiling of Tyrosine Kinase Substrates
09:30 - 09:30 | Presenter: Sven Hillinger | Author(s): S. Arni, C. Caviezel, Walter Weder
- Abstract
Loading... -
+
P1.02-006 - Arsenic Promotes Persistent Alterations in the Lung PiRNA Transcriptome to Target Epigenetic Pathways
09:30 - 09:30 | Presenter: Victor D Martinez | Author(s): K. Ng, Erin Anne Marshall, Adam Patrick Sage, Brenda C. Minatel, I. Jurisica, W.L. Lam
- Abstract
Loading... -
+
P1.02-007 - TP53 and DNA-Repair Gene Polymorphisms as Risk Factors for the Development of Advanced Lung Adenocarcinoma in Serbia
09:30 - 09:30 | Presenter: Jelena Spasic | Author(s): A. Krivokuca, B. Zaric, D. Radosavljevic, B. Perin, S. Radulovic, R. Jankovic, M. Cavic
- Abstract
Loading... -
+
P1.02-008 - Expression of Mismatch Repair Proteins Associates with Survival and Response to EGFR Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients
09:30 - 09:30 | Presenter: Hsiang-Ling Ho | Author(s): Y. Yeh, W. Hsieh, Teh-Ying Chou
- Abstract
Loading... -
+
P1.02-009 - Accumulation of Mutations in Background Normal Lung Tissue Constitutes a Major Lung Cancer Risk
09:30 - 09:30 | Presenter: Emi Kubo | Author(s): H. Takeshima, S. Yamashita, N. Motoi, T. Ushijima
- Abstract
Loading... -
+
P1.02-010 - Novel Role of hSSB2 in the Base Excision Repair Pathway (BER)
09:30 - 09:30 | Presenter: Mark Adams | Author(s): A. Naqi, M. Fisher, S. Beard, J. Burgess, Kenneth Obyrne, D. Richard
- Abstract
Loading... -
+
P1.02-011 - XRCC6BP1: A Key Player in the DNA Repair of Cisplatin Resistant NSCLC Cells
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): S. Singh, R. Farrell, E. Foley, Y. He, L. Brady, V. Young, R. Ryan, S. Nicholson, N. Leonard, S. Cuffe, Stephen P Finn
- Abstract
Loading... -
+
P1.02-012 - Profiling DNA Repair in Lung Cancer
09:30 - 09:30 | Presenter: Alexander Dobrovic | Author(s): H. Do, G. Wright
- Abstract
Loading... -
+
P1.02-013 - ATM Mutation as a Predictor for Mutation Burden in NSCLC
09:30 - 09:30 | Presenter: D. Gwyn Bebb | Author(s): L.F. Petersen
- Abstract
Loading... -
+
P1.02-014 - TGFalpha Promotes Growth of Lung Tumors Carrying EGFR Mutation but not KRAS Mutation in Transgenic Mouse Models in Vivo
09:30 - 09:30 | Presenter: Koichi Tomoshige | Author(s): G. Minzhe, T. Tsuchiya, T. Fukazawa, Y. Naomoto, T. Nagayasu, Y. Maeda
- Abstract
Loading... -
+
P1.02-015 - Comparison of Study Models of Lung Cancer
09:30 - 09:30 | Presenter: Yoshito Yamada | Author(s): J. Jang, F. Janker, Walter Weder, W. Jungraithmayr
- Abstract
Loading... -
+
P1.02-016 - Establishment of Lung Adenocarcinoma Organoid Cultures
09:30 - 09:30 | Presenter: Hirotsugu Notsuda | Author(s): N. Radulovich, C. Ng, L. Tamblyn, M. Cabanero, M. Li, N. Pham, Ming Sound Tsao
- Abstract
Loading... -
+
P1.02-017 - Freely Floating Cancer Cells in Lymph Node Sinuses of Hilar Lymph Node Positive Lung Cancer Patients
09:30 - 09:30 | Presenter: Yusuke Nakamura | Author(s): M. Mukai, S. Hiraiwa, K. Kishima, T. Sugiyama, T. Tajiri, S. Yamada, M. Iwazaki
- Abstract
Loading... -
+
P1.02-018 - Number of Cancer Cells in Lung Adenocarcinoma Specimen – Correlation with Noguchi's Classification, WHO Pathologic Type, and Prognosis
09:30 - 09:30 | Presenter: Takashi Inoue | Author(s): Y. Nakazato, M. Nishihira, O. Araki, Y. Karube, S. Maeda, S. Kobayashi, M. Chida
- Abstract
Loading... -
+
P1.02-019 - Dual Role of Notch in Lung Cancer
09:30 - 09:30 | Presenter: Sara Sinicropi-Yao | Author(s): J. Amann, K. Coombes, David P Carbone
- Abstract
Loading... -
+
P1.02-020 - Acinar-Predominant Pattern Correlates with Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung
09:30 - 09:30 | Presenter: Gengpeng Lin | Author(s): H. Li, C. Xie
- Abstract
Loading... -
+
P1.02-021 - Can 18F-FDG PET/CT Predict the Pathological Necrosis and Microvessel Density in Lung Adenocarcinomas
09:30 - 09:30 | Presenter: Young Wha Koh | Author(s): S.J. Lee, S.Y. Park
- Abstract
Loading... -
+
P1.02-022 - Spontaneous Regression of Primary Pulmonary Synovial Sarcoma; A Case Report
09:30 - 09:30 | Presenter: Naoko Miyata | Author(s): H. Tsunezuka, N. Ishikawa, T. Furuya, C. Nakazono, S. Ishihara, Satoru Okada, D. Kato, Junichi Shimada, E. Konishi, M. Inoue
- Abstract
Loading... -
+
P1.02-023 - TGF-β Signaling Mediated by Fibroblasts is Associated with the Histological Subtypes of Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Ryo Sato | Author(s): T. Semba, H. Ichiyasu, K. Fujii, Hideyuki Saya, Y. Arima
- Abstract
Loading... -
+
P1.02-024 - Correlation of Maximal Tumor Diameter between Pathology Specimen and CT in Nonsmall Cell Lung Cancer: A Pilot Study
09:30 - 09:30 | Presenter: Heae Surng Park | Author(s): C.H. Park, S. Lee, T.H. Kim
- Abstract
Loading... -
+
P1.02-025 - A Case of Primary Peripheral Epithelial–Myoepithelial Carcinoma of the Lung
09:30 - 09:30 | Presenter: Daisuke Eriguchi | Author(s): H. Takahashi, O. Uchida, Eiji Nakajima, T. Tanaka, K. Murakami, Norihiko Ikeda
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-027 - Minute Pulmonary Meningothelial-Like Nodules Presenting as Multiple Ground-Glass Density Nodules (GGNs): A Case Report
09:30 - 09:30 | Presenter: Yeon Bi Han | Author(s): Hyun Jung Kwon, E. Park, H. Kim, Jin-Haeng Chung
- Abstract
Loading... -
+
P1.02-028 - Pathways Involved in Early Stage Lung Cancers
09:30 - 09:30 | Presenter: Vilde D Haakensen | Author(s): S. Nygårad, V. Nygaard, L.H. Jørgensen, S. Solberg, E. Hovig, O.T. Brustugun, O.C. Lingjærde, Å. Helland
- Abstract
Loading... -
+
P1.02-029 - Pulmonary Adenofibroma with Cystic Change: A Case Report
09:30 - 09:30 | Presenter: Eunhyang Park | Author(s): Y.B. Han, H.J. Kwon, H. Kim, Jin-Haeng Chung
- Abstract
Loading... -
+
P1.02-030 - The Effect of Chronic Obstructive Pulmonary Disease on the Tumor Stroma in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yasuhiko Ohshio | Author(s): K. Hayashi, K. Okamoto, R. Kaku, Yoko Kataoka, Y. Kawaguchi, M. Ohshio, Tomoyuki Igarashi, M. Hashimoto, Koji Teramoto, J. Hanaoka
- Abstract
Loading... -
+
P1.02-031 - Clinicopathological Study of 16 Cases with Pulmonary Pleomorphic Carcinoma
09:30 - 09:30 | Presenter: Fumi Ohsawa | Author(s): M. Kamiyoshihara, Hitoshi Igai, Takashi Ibe, Ryohei Yoshikawa
- Abstract
Loading... -
+
P1.02-032 - Clinicopathological Profile of Invasive Mucinous Adenocarcinoma Based on Evaluation of Invasive Components
09:30 - 09:30 | Presenter: Yuichi Mitsui | Author(s): H. Fushimi, Y. Tanio, K. Ueno, J. Uchida, M. Suzuki, Y. Shirai, K. Matsumoto, K. Kuno, T. Yanase, Y. Funakoshi, H. Takabatake, K. Shimazu, A. Kikuyama
- Abstract
Loading... -
+
P1.02-033 - Differentiating of Cytomorphological Characteristics in Non-Small Cell Lung Cancer Predicts Value of Radiologic Features
09:30 - 09:30 | Presenter: Ryota Tanaka | Author(s): M. Fujiwara, K. Tachibana, J. Miura, R. Shimizu, Y. Nagashima, T. Miya, H. Takei, J. Shibahara, H. Kamma, H. Kondo
- Abstract
Loading... -
+
P1.02-034 - Non-Invasive Qualitative Diagnosis of Lung Cancer Enabled by Spectrum Analysis of Ultrasound
09:30 - 09:30 | Presenter: Takashi Anayama | Author(s): R. Ihara, T. Aoki, E. Narukami, Takahiro Nakajima, Hironobu Wada, Kentaro Hirohashi, R. Miyazaki, Kazuhiro Yasufuku, K. Orihashi
- Abstract
Loading... -
+
P1.02-035 - Human Papillomavirus Infection in Lung Squamous Cell Carcinoma and Correlation to p16 INK4a Expression from an Argentine Population
09:30 - 09:30 | Presenter: Valeria Cecilia Denninghoff | Author(s): M.M. García Falcone, M.T. Cuello, A.J. Garcia, G.(. Recondo, M.A. Avagnina, G. Recondo
- Abstract
Loading... -
+
P1.02-036 - Fine Needle Aspiration as a Diagnostic Tool in Lung Cancer: Worth Pursuing?
09:30 - 09:30 | Presenter: Luiz H. Araujo | Author(s): E.T. Cunha, A.M.C. Sousa, H. Paiva, F. Rodrigues, M.T. Accioly, L. Bastos, C.F. Silva, N. Carvalho, C.A.M. Sousa, I. Small, C.G. Ferreira
- Abstract
Loading... -
+
P1.02-037 - Pulmonary Carcinoid Tumors: A Prognostic Implications of Ki-67 Proliferative Index
09:30 - 09:30 | Presenter: Renata Langfort | Author(s): Piotr Rudzinski, E. Szczepulska, B. Maksymiuk, T. Orlowski, M. Szolkowska
- Abstract
Loading... -
+
P1.02-038 - Bilateral Combined Lymphangioleiomyomatosis and Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia with Typical Carcinoids
09:30 - 09:30 | Presenter: Jan Hinrich Von Der Thüsen | Author(s): P. Atmodimedjo, E. Dubbink, J. Miedema, W. Dinjens
- Abstract
Loading... -
+
P1.02-039 - Preventive and Therapeutic Action of Id1 Inhibition in KRAS-Mutant (KM) Lung Adenocarcinoma (LAC) Tumors in a Xenograft Murine Model
09:30 - 09:30 | Presenter: Marta Roman Moreno | Author(s): S. Vicent, I. López, I. Baraibar, J. Jang, Christian Rolfo, Ignacio Gil-Bazo
- Abstract
Loading... -
+
P1.02-040 - Genetic Risk Evaluation in Families with Lung Cancer History in High Lung Cancer Mortality Region of Xuanwei, China
09:30 - 09:30 | Presenter: Madiha Kanwal | Author(s): X. Ding, M. Zhanshan, P. Wang, H. Yun-Chao, C. Yi
- Abstract
Loading... -
+
P1.02-041 - Mutation of SWI/SNF Complex Genes Is Frequent in Poorly Differentiated, Mesenchymal-Like Lung Cancer without Major Driver Mutation
09:30 - 09:30 | Presenter: Taichiro Yoshimoto | Author(s): Daisuke Matsubara, Toshiro Niki
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-044 - Relationship between RET Rearrangement and Thymidylate Synthase mRNA Expression in Non-Small Cell Lung Cancer Tissues
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Tian, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-045 - PIK3CA Mutations in Chinese Patients with Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): B. Wu, Chunwei Xu, W. Wang, Xiaobing Zheng, Wu Zhuang, Z. Song, G. Lin, X. Chen, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-046 - Mutational Subtypes and Prognosis of Non-Small-Cell Lung Cancer Harboring HER2 Mutations
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Huang, Z. Song, Y. Chen, W. Liu, Rongrong Chen, Y. Guan, X. Yi, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-047 - Mutational Features and Prognosis of Non-Small-Cell Lung Cancer Harboring RAS Mutations
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Y. Zhu, Chunwei Xu, W. Wang, X. Liao, Wu Zhuang, Z. Song, Y. Chen, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-048 - Somatic Mutation Analysis of RB1 Gene in Chinese Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): W. Wang, Chunwei Xu, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-049 - Detection of CDKN2A Gene Mutations in Patients with Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): S. Wang, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-050 - Pan-Can Analysis of miRNAs at the Imprinted Chromosome 14q32 Locus Reveals a Unique Pattern of Deregulation in NSCLC
09:30 - 09:30 | Presenter: Jhon Ralph Enterina | Author(s): W.L. Lam
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-052 - Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma
09:30 - 09:30 | Presenter: Masatsugu Kuraoka | Author(s): Vishwa Jeet Amatya, Kei Kushitani, A.S. Mawas, Y. Miyata, Morihito Okada, T. Kishimoto, K. Inai, T. Nishisaka, T. Sueda, Y. Takeshima
- Abstract
Loading... -
+
P1.02-053 - A New Strategy of Adjuvant Chemotherapy for Lung Cancer Based on the Expression of Anti-Aging Gene Klotho
09:30 - 09:30 | Presenter: Kyoshiro Takegahara | Author(s): Jitsuo Usuda, T. Inoue, T. Sonokawa
- Abstract
Loading... -
+
P1.02-054 - The Molecular Characterisation of Lung Adenocarcinoma Subgroups
09:30 - 09:30 | Presenter: Elizabeth Starren | Author(s): S. Willis-Owen, S.K. Lo, Andrew G Nicholson, W. Cookson, M. Moffatt
- Abstract
Loading... -
+
P1.02-055 - Genotyping Squamous Cell Lung Carcinoma Among Hispanics (Geno1.1-CLICaP)
09:30 - 09:30 | Presenter: Andrés F. Cardona | Author(s): Oscar Arrieta, L. Rojas, Z.L. Zatarain-Barron, L. Corrales, Claudio Martin, J. Rodriguez, J. Rodriguez, P. Archila, Alejandro Ruiz-Patiño, Rafael Rosell
- Abstract
Loading... -
+
P1.02-056 - BRAF Non-V600E Mutations Recurrently Found in Non-Small Cell Lung Cancer in Chinese Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Q. Xu, W. Wang, Chunwei Xu, Wu Zhuang, Z. Song, Y. Zhu, Z. Xu, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-057 - Analysis of C-MET Amplification Non-Small Cell Lung Cancer Cell Blocks from Pleural Effusion
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Y. Tian, J. Xu, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-058 - Molecular Characteristics and Outcome of Chinese Patients with Non-Small Cell Lung Cancer Harboring NFE2L2 Mutations
09:30 - 09:30 | Presenter: Gang Chen | Author(s): W. Wang, Chunwei Xu, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-060 - Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung
09:30 - 09:30 | Presenter: Yohei Yurugi | Author(s): W. Fujiwara, Y. Kidokoro, K. Hosoya, T. Ohno, T. Sakabe, Yasuaki Kubouchi, M. Wakahara, Y. Takagi, T. Haruki, K. Nosaka, K. Miwa, K. Araki, Y. Taniguchi, T. Shiomi, H. Nakamura, Y. Umekita
- Abstract
Loading... -
+
P1.02-061 - Podoplanin Expression in Cancer-Associated Fibroblasts Predicts Unfavourable Prognosis in Patients with Stage IA Adenocarcinoma
09:30 - 09:30 | Presenter: Yasuaki Kubouchi | Author(s): W. Fujiwara, Y. Kidokoro, T. Ohno, Yohei Yurugi, M. Wakahara, Y. Takagi, K. Miwa, K. Araki, Y. Taniguchi, H. Nakamura, Y. Umekita
- Abstract
Loading... -
+
P1.02-062 - Ring Finger Protein 38 Promote Non-Small Cell Lung Cancer Progression by Endowing Cell EMT Phenotype
09:30 - 09:30 | Presenter: Jian-Yong Ding | Author(s): C. Jin, D. Xiong
- Abstract
Loading... -
+
P1.02-063 - Tumor Heterogeneity Analyses by Integrated Proteo-Genomics of Thoracic Tumors from Sequential Biopsies and Warm Autopsies
09:30 - 09:30 | Presenter: Udayan Guha | Author(s): N. Roper, X. Zhang, T.K. Maity, S. Gao, A. Venugopalan, R. Biswas, C.M. Cultraro, C. Kim, E. Padiernos, A. Rajan, Anish Thomas, R. Hassan, D. Kleiner, S. Hewitt, J. Khan
- Abstract
Loading... -
+
P1.02-064 - Proteomic Analysis of Exosome Purified Using a Novel Reagent
09:30 - 09:30 | Presenter: Ayako Kurimoto | Author(s): T. Inuzuka
- Abstract
Loading... -
+
P1.02-065 - Histone Deacetylase Inhibition Alters Stem Cell Phenotype in Gefitinib-Resistant Lung Cancer Cells with EGFR Mutation
09:30 - 09:30 | Presenter: Fariz Nurwidya | Author(s): F. Takahashi, Moulid Hidayat, I. Kobayashi, Aditya Wirawan, M. Kato, K. Tajima, N. Shimada, I. Takeda, M. Tajima, N. Matsumoto, K. Kanemori, Y. Koinuma, F. Yunus, Sita Andarini, K. Takahashi
- Abstract
Loading... -
+
P1.02-066 - Cancer Stem Cells in Pulmonary High Grade Neuroendocrine Carcinoma: a Series of 23 Cases from Eastern India
09:30 - 09:30 | Presenter: Prasanta Raghab Mohapatra | Author(s): S. Patra, P. Mishra, S. Purkait, M. Sable, S. Padhi, M. Sethy, N. Sahoo, M. Nayak, R. Gharei, S. Bhuniya, M.K. Panigrahi
- Abstract
Loading... -
+
P1.02-067 - FGF1 and IGF1 Co-Stimulation Promoted the Amplification and Cancer Stemness of Lung Cancer Cells under 3D Culture Condition
09:30 - 09:30 | Presenter: Rui Zhang
- Abstract
Loading... -
+
P1.02-068 - Effects of Pirfenidone Targeting EMT and Tumor-Stroma Interaction as Novel Treatment for Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Ayako Fujiwara | Author(s): Yasushi Shintani, S. Funaki, T. Kawamura, Ryu Kanzaki, E. Fukui, M. Minami, Meinoshin Okumura
- Abstract
Loading... -
+
P1.02-069 - Pemetrexed-Resistant Non-Small Cell Lung Cancer Cell Lines Have Novel Drug-Resistant Mechanisms
09:30 - 09:30 | Presenter: Ryosuke Tanino | Author(s): Y. Tsubata, N. Harashima, M. Harada, T. Isobe
- Abstract
Loading... -
+
P1.02-070 - Identification of Lung Cancer Specific Differentially Methylated Regions Using Genome-Wide DNA Methylation Study
09:30 - 09:30 | Presenter: Yoonki Hong
- Abstract
Loading... -
+
P1.02-071 - SFN Stabilizes Oncoproteins through Binding with SKP1 to Block SCFFBW7 Ubiquiting Ligase
09:30 - 09:30 | Presenter: Jeongmin Hong | Author(s): Aya Shiba, Y. Kim, M. Noguchi
- Abstract
Loading... -
+
P1.02-071a - Targeting Human Single Stranded DNA Binding Protein (hSSB) 1, a Novel Prognostic Factor, in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): D. Boucher, N. Ashton, J. Burgess, E. Bolderson, Martin P Barr, Steven G. Gray, K. Gately, L. Croft, D. Richard
- Abstract
Loading... -
+
P1.02-071b - SASH1 Is a Prognostic Indicator and Future Target in NSCLC
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): J. Burgess, E. Bolderson, Mark Adams, S. Zhang, S. Fox, G. Wright, R. Young, Ben J Solomon, Martin P Barr, Steven G. Gray, D. Richard
- Abstract
Loading...
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-001 - Verification and Implementation of the VENTANA Anti-ALK D5F3 Antibody in Detecting ALK Rearrangement in NSCLC
09:30 - 09:30 | Presenter: Haider Al-Najjar | Author(s): N. Nadira, C. Higgins, A. Wallace, J. Harris, S. Bailey, D. Shelton, S. Thiryayi, D. Rana
- Abstract
Loading... -
+
P1.03-002 - Crizotinib-Associated Toxic Epidermal Necrolysis in an ALK-Positive Advanced NSCLC Patient
09:30 - 09:30 | Presenter: Shaoyu Yang | Author(s): Xueqin Chen, Shenglin Ma
- Abstract
Loading... -
+
P1.03-003 - Clinical Implications of an Analysis of Crizotinib Pharmacokinetics Co-Administered with Dexamethasone in Patients with NSCLC
09:30 - 09:30 | Presenter: Swan Lin | Author(s): D. Nickens, M. Patel, K. Wilner, W. Tan
- Abstract
Loading... -
+
P1.03-004 - Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status
09:30 - 09:30 | Presenter: Hirotsugu Kenmotsu | Author(s): E. Iwama, Yasushi Goto, T. Harada, S. Tsumura, H. Sakashita, Y. Mori, N. Nakagaki, Y. Fujita, M. Seike, A. Bessho, M. Ono, A. Okazaki, H. Akamatsu, R. Morinaga, S. Ushijima, T. Shimose, S. Tokunaga, A. Hamada, Nobuyuki Yamamoto, Yoichi Nakanishi, K. Sugio, Isamu Okamoto
- Abstract
Loading... -
+
P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9
09:30 - 09:30 | Presenter: Hidehito Horinouchi | Author(s): M. Maemondo, T. Hida, M. Takeda, K. Hotta, F. Hirai, Y.H. Kim, S. Matsumoto, Tetsuya Mitsudomi, Takashi Seto, S. Moizumi, K. Tokushige, B. Hatano, Makoto Nishio
- Abstract
Loading... -
+
P1.03-006 - Clinicopathological Features and Poor Outcome for ALK Inhibitors of Squamous Cell Lung Cancer with ALK-Rearrangement
09:30 - 09:30 | Presenter: Hiroaki Motomura | Author(s): J. Watanabe, S. Togo, I. Sumiyoshi, Y. Namba, K. Suina, T. Mizuno, K. Kadoya, M. Iwai, T. Nagaoka, S. Sasaki, T. Hayashi, T. Uekusa, K. Abe, Y. Urata, F. Sakurai, H. Mizuguchi, S. Kato, K. Takahashi
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-008 - Analysis of Data on Interstitial Lung Disease Onset and Its Risk Following Treatment of ALK-positive NSCLC with Xalkori
09:30 - 09:30 | Presenter: Akihiko Gemma | Author(s): Masahiko Kusumoto, Y. Kurihara, N. Masuda, S. Banno, Y. Endo, H. Houzawa, N. Ueno, E. Ohki, A. Yoshimura
- Abstract
Loading... -
+
P1.03-009 - A Lung Adenocarcinoma with a STRN-ALK Rearrangement Was Poorly Responsive to Alectinib Treatment
09:30 - 09:30 | Presenter: Yuko Iida | Author(s): Yoko Nakanishi, N. Takahashi, H. Nishimaki, T. Nishizawa, Yoshiko Nakagawa, T. Shimizu, Y. Gon, S. Masuda, S. Hashimoto
- Abstract
Loading... -
+
P1.03-010 - Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Reina Imase | Author(s): S. Endo, Y. Sasahara, T. Shinmura, T. Ozawa, H. Majima, T. Hara, Hiroyuki Shimada, S. Yamauchi, Y. Sakakibara, A. Kobayashi, K. Yamazaki, Y. Jin, K. Yamanaka, O. Matsubara
- Abstract
Loading... -
+
P1.03-011 - Clinical Outcomes Correlated with Percentage of Positive Anaplastic-Lymphoma Kinase Cells Tested by FISH Analysis in NSCLC.
09:30 - 09:30 | Presenter: Katy Louise Clarke | Author(s): H. Dickinson, K. Spencer, E. Verghese, K.N. Franks, S. Sabir, R. Bayliss
- Abstract
Loading... -
+
P1.03-012 - Using Computational Modeling to Simulate Clinical Response of ALK Inhibitors to G1202R ALK and Possible Mechanisms of Resistance
09:30 - 09:30 | Presenter: Chien-Ting Liu | Author(s): C. Chen
- Abstract
Loading... -
+
P1.03-013 - Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): J. Remon, C. Nicotra, M. Noerholm, K. Brinkmann, David Planchard, C. Jovelet, E. Auclin, C. Flinspach, J. Hurley, J. Skog, A. Gazzah, C. Caramella, J. Adam, L. Lacroix, N. Auger, L. Friboulet, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
P1.03-014 - Saline Alone vs Saline plus Mannitol Hydration for the Prevention of Acute Cisplatin Nephrotoxicity: A Randomized Trial
09:30 - 09:30 | Presenter: Wilfred Dela Cruz | Author(s): F. Flynt, S. Terrazzino, N. Hullinger, M. King, J. Aden, D. Nelson, T. Byrd
- Abstract
Loading... -
+
P1.03-015 - The Relationship between the UGT1A1*27 and UGT1A1*7 Genetic Polymorphisms and Irinotecan-Related Toxicities in Patients with Lung Cancer
09:30 - 09:30 | Presenter: Minoru Fukuda | Author(s): M. Okumura, K. Arimori, A. Takahira, M. Mori, D. Nakamura, M. Shimada, Hirokazu Taniguchi, H. Gyotoku, H. Senju, T. Ikeda, H. Yamaguchi, K. Nakatomi, T. Tsuchiya, H. Mukae, Kazuto Ashizawa
- Abstract
Loading... -
+
P1.03-016 - Video-Thoracoscopic Pulmonary Resection Avoids Delay and Increase Adjuvant Chemotherapy Compliance for Non-Small Cell Lung Carcinoma
09:30 - 09:30 | Presenter: Ak?n Ozturk | Author(s): Ç.S. Tezel, R.S. Evman, I. Kolbaş, V.S. Baysungur, H. Kıral, L. Alpay, I. Yalçınkaya
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-018 - Effectiveness of Supportive Care Drugs in Lung Cancer Patients Undergoing 1st Line Chemotherapy in a Resource Limited Setting
09:30 - 09:30 | Presenter: Digambar Behera | Author(s): B. Mylliemngap, Valliappan Muthu, Navneet Singh
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-021 - A Prospective Observational Study to Evaluate Incidence of Thromboembolic Events during Platinum Based Chemotherapy in Lung Cancer
09:30 - 09:30 | Presenter: Vikas Talreja | Author(s): A. Joshi, V. Noronha, Vijay Patil, K. Prabhash, S. Kate
- Abstract
Loading... -
+
P1.03-022 - A Phase 1B Study of TRC105 in Combination with Paclitaxel/Carboplatin and Bevacizumab in Patients with Stage 4 Non-Squamous Cell Lung Cancer
09:30 - 09:30 | Presenter: B. Simpson | Author(s): Francisco Robert, C. Theuer, M. Jerome, J. Keef, D. Miley
- Abstract
Loading... -
+
P1.03-023 - The Real-World Practice of Bevacizumab Plus Chemotherapy in Stage IV Lung Adenocarcinoma: A Single Institute Experience
09:30 - 09:30 | Presenter: Yen-Hao Chen | Author(s): C. Wang
- Abstract
Loading... -
+
P1.03-024 - Efficacy of Carboplatin-Vinorelbine in Advanced NSCLC Patients at Persahabatan Hospital, Jakarta - Indonesia
09:30 - 09:30 | Presenter: Putu Ayu Diah | Author(s): Sita Andarini, Jamal Zaini, E. Syahruddin, A. Hudoyo
- Abstract
Loading... -
+
P1.03-025 - Combination Therapy with Carboplatin and Hyperoxia Synergistically Enhances Suppression of Benzo[a]Pyrene Induced Lung Cancer
09:30 - 09:30 | Presenter: Sang Haak Lee | Author(s): S.K. Kim, Chan Kwon Park, Jin Woo Kim, S.J. Kim, H.S. Moon
- Abstract
Loading... -
+
P1.03-026 - Interim Results of a Phase I Study of Nivolumab plus Nab-Paclitaxel/Carboplatin in Patients with NSCLC
09:30 - 09:30 | Presenter: Jonathan W. Goldman | Author(s): D. Waterhouse, B. George, P.J. O'Dwyer, T. Chen, N. Trunova, Karen Kelly
- Abstract
Loading... -
+
P1.03-027 - Randomized Phase 2 Study Comparing CBDCA+PTX+BEV and CDDP+PEM+BEV in Treatment-Naïve Advanced Non-Sq NSCLC (CLEAR Study)
09:30 - 09:30 | Presenter: Shinji Atagi | Author(s): H. Udagawa, E. Sugiyama, O. Hataji, Fumihiro Tanaka, A. Niimi, H. Kida, Y. Kawa, T. Yamanaka, Koichi Goto
- Abstract
Loading... -
+
P1.03-028 - A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Untreated Stage IV Squamous Cell Lung Cancers
09:30 - 09:30 | Presenter: Paul K. Paik | Author(s): A. Srikakulum, L. Ahn, A. Plodkowski, K. Ng, D. McFarland, J. Fiore, A. Iqbal, J. Eng, Mark G Kris, Charles M Rudin
- Abstract
Loading... -
+
P1.03-029 - Study of Plasma Homocysteine as a Marker of Toxicity and Depression in Patients Treated with Pemetrexed-Based Chemotherapy
09:30 - 09:30 | Presenter: Mary Obrien | Author(s): A.R. Minchom, R. Gunapala, D. Walder, R. Kumar, J. Bhosle, Sanjay Popat, N. Yousaf
- Abstract
Loading... -
+
P1.03-030 - Prognostic Impact of the Presence of COPD in Patients with NSCLC under Conventional Systemic Chemotherapy
09:30 - 09:30 | Presenter: Jin Woo Kim | Author(s): H.S. Moon, Sang Haak Lee, Sung Kyoung Kim
- Abstract
Loading... -
+
P1.03-031 - Adherence and Feasibility of 2 Treatment Schedules of S-1 as Adjuvant Chemotherapy in Completely Resected Lung Cancer
09:30 - 09:30 | Presenter: Takaharu Kiribayashi | Author(s): Y. Hata, K. Kishi, M. Nagashima, T. Nakayama, S. Ikeda, M. Kadokura, Y. Ozeki, H. Otsuka, Y. Murakami, S. Kusachi, K. Takagi, Akira Iyoda
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-033 - Long-Term Outcome of Histoculture Drug Response Assay Guided Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yoshimitsu Hirai | Author(s): Tatsuya Yoshimasu, A. Fusamoto, Y. Aoishi, Y. Yata, H. Nishiguchi, Takuya Ohashi, M. Miyasaka, M. Kawago, S. Oura, Y. Nishimura
- Abstract
Loading... -
+
P1.03-034 - Therapeutic Effect of Novel Leucyl-tRNA Synthetase Inhibitor, B1206, in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Eun Young Kim | Author(s): A. Kim, J.M. Lee, J.M. Han, Yoon Soo Chang
- Abstract
Loading... -
+
P1.03-035 - Efficacy of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC
09:30 - 09:30 | Presenter: Joaquim Bosch Barrera | Author(s): E. Sais, S. Verdura, E. Cuyas, D. Roa, A. Hernández, A. Izquierdo, E. Teixidor, W. Carbajal, M. Lopez, J. Brunet, J.A. Menendez
- Abstract
Loading... -
+
P1.03-036 - Adjuvant Chemotherapy with Uracil-Tegafur for Pathological T1aN0M0 Lung Adenocarcinoma with Lymphatic Vessel Invasion
09:30 - 09:30 | Presenter: Yoshitaka Kitamura | Author(s): W. Nishio, H. Tanaka, K. Minami, H. Okuma, M. Yoshimura
- Abstract
Loading... -
+
P1.03-037 - A Phase II Study of Adjuvant Chemotherapy with Docetaxel plus Nedaplatin for Completely Resected Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Koji Teramoto | Author(s): Y. Namura, K. Hayashi, K. Ishida, K. Ueda, K. Okamoto, R. Kaku, T. Hori, Y. Kawaguchi, Tomoyuki Igarashi, M. Hashimoto, Y. Ohshio, S. Kitamura, M. Motoishi, Y. Suzumura, S. Sawai, J. Hanaoka, Y. Daigo
- Abstract
Loading... -
+
P1.03-038 - A Phase I Trial of Afatinib and Bevacizumab in Untreated Patients with Advanced NSCLC Harboring EGFR-Mutations: OLCSG1404
09:30 - 09:30 | Presenter: Shoichi Kuyama | Author(s): Kenichiro Kudo, T. Tamura, T. Nishi, Daijiro Harada, A. Bessho, N. Fujimoto, D. Minami, K. Aoe, T. Ninomiya, K. Kiura
- Abstract
Loading... -
+
P1.03-039 - Therapeutic Inhibition of the Cancer Stem Cell Marker, ALDH1, a Promising Mechanism by Which Cisplatin Sensitivity Can Be Restored in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, S. Cuffe, Stephen P Finn, S. Nicholson, R. Ryan, V. Young, N. Leonard, Kenneth Obyrne
- Abstract
Loading... -
+
P1.03-040 - Smokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience
09:30 - 09:30 | Presenter: Perran Fulden Yumuk | Author(s): O. Ercelep, T.A. Telli, O. Alan, R. Hasanov, E.T. Simsek, S. Halil, M.A. Ozturk, N.A. Babacan, S. Kaya, H. Kaya, Faysal Dane
- Abstract
Loading... -
+
P1.03-041 - Exploitation of the Cancer Stem Cell Marker ALDH1 Within the Vitamin a/Retinoic Acid Axis Promotes Re-Sensitisation of Cisplatin Resistant NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, M. Gallagher, B. Ffrench, C. Gasch, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P1.03-042 - BBI608, a Small Molecule Stemness Inhibitor, Circumvents Cisplatin Resistance in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P1.03-043 - 30-Day Mortality Following Systemic Anti-Cancer Treatment for NSCLC at a Single Canadian Cancer Centre
09:30 - 09:30 | Presenter: Gwyn Bebb | Author(s): A.J.W. Gibson, R.A. Tudor, A. D'Silva, A.A. Elegbede, S. Otsuka, H. Li, W. Cheung
- Abstract
Loading... -
+
P1.03-044 - Exploratory Analysis of Lung Cancer Patients in a Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine
09:30 - 09:30 | Presenter: Lyudmila Bazhenova | Author(s): R.H. Tran, J.E. Grilley-Olson, N. Sharma, A. Combest, I. Bobe, A. Osada, K. Takahasi, J. Balkissoon, A. Camp, A. Masada, D.J. Reitsma, V. Subbiah
- Abstract
Loading... -
+
P1.03-045 - HER-2 Mutation Is Not a Prognostic Factor Treated with First-Line Chemotherapy in NSCLC Patients
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): C. Zhao, X. Li, C. Su, X. Chen, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P1.03-046 - A Retrospective Analysis of Correlation Between Cytokines in TME and Therapeutic Effect of Advanced Lung Cancer Chemotherapy in China
09:30 - 09:30 | Presenter: Chunxia Su | Author(s): J. Shen, J. Zhao, A. Xiong, X. Li
- Abstract
Loading... -
+
P1.03-047 - Carboplatin/ Weekly Nab-PTX in Elderly Patients with Previously Untreated Advanced Squamous NSCLC Selected Based on MNA-SF
09:30 - 09:30 | Presenter: So Takata | Author(s): T. Shiroyama, M. Tamiya, S. Minami, T. Uenami, H. Suzuki, N. Okamoto, K. Komuta, T. Hirashima, A. Kumanogoh, T. Kijima
- Abstract
Loading... -
+
P1.03-048 - miR-34a and the Micromanagement of Cancer Stemness and Resistance in NSCLC. Does It Hold Therapeutic Benefit?
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, M. Gallagher, B. Ffrench, C. Gasch, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P1.03-049 - Phase II Study of S-1 plus Bevacizumab Combination Therapy for Patients Previously Treated for Non-Squamous Non–Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kentaro Masuhiro | Author(s): Y. Nishijima-Futami, S. Minami, S. Futami, T. Koba, M. Higashiguchi, M. Tamiya, H. Suzuki, T. Hirashima, K. Komuta, T. Kijima
- Abstract
Loading... -
+
P1.03-050 - Clinical Consequences, Quality of Life, and Management of Neutropenic NSCLC Patients in the REVEL Trial
09:30 - 09:30 | Presenter: David S Ettinger | Author(s): Oscar Arrieta, N.A. Karaseva, Gee-Chen Chang, A. Rittmeyer, Y. Huang, R. Cheng, R. Varea, H. Ostojic, G. Mi, K.B. Winfree, E. Alexandris, F.W. Chan-Diehl, Frederico Cappuzzo
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-052 - Comparing EGFR-TKI with EGFR-TKI plus Chemotherapy as 1st Line Treatment in Advanced NSCLC Patients with Both Mutated EGFR and Bim Polymorphism
09:30 - 09:30 | Presenter: Yayi He | Author(s): C. Zhao, X. Li, Shengxiang Ren, Tao Jiang, J. Zhang, C. Su, X. Chen, Weijing Cai, G. Gao, W. Li, Fengying Wu, J. Li, J. Zhao, Fei Zhou, Q. Hu, Fred R. Hirsch, Caicun Zhou
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
P1.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P1.04-001 - Osimertinib with Ramucirumab or Necitumumab in Advanced T790M-positive EGFR-Mutant NSCLC: Preliminary Ph1 Study Results
09:30 - 09:30 | Presenter: Helena Yu | Author(s): David Planchard, James Chih-Hsin Yang, K.H. Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, S. He, K. Wolff, B.H. Chao, Luis Paz-Ares
- Abstract
Loading... -
+
P1.04-002 - Tolerability of Osimertinib and Its Impact on Quality of Life in Advanced Non-Small Cell Lung Cancer Patients: The ARPA Study
09:30 - 09:30 | Presenter: Enrica Capelletto | Author(s): M.V. Pacchiana, E. De Luca, M.L. Reale, M. Gianetta, Silvia Novello
- Abstract
Loading... -
+
P1.04-003 - The International Lung Screen Trial: A Multi-Centre Study to Evaluate LDCT Screening Selection Criteria and Nodule Management
09:30 - 09:30 | Presenter: Kuan Pin Lim | Author(s): Fraser Brims, A. McWilliams, M. Tammemägi, C. Berg, H.M. Marshall, Emily Stone, R. Manser, K. Canfell, L. Connelly, J. Yee, Kwun M Fong, Stephen Lam
- Abstract
Loading... -
+
P1.04-004 - Phase I/Ib Study of Nivolumab and Veliparib in Advanced Solid Tumors and Lymphoma with and without Alterations in Selected DNA Repair Genes
09:30 - 09:30 | Presenter: Wade Thomas Iams | Author(s): Y.K. Chae, S. Pai, R. Costa, T. Taxter, N. Mohindra, V. Villaflor, B. Pro, F.J. Giles
- Abstract
Loading... -
+
P1.04-005 - Phase 2 Study of Nivolumab and Metformin in Advanced Non-Small Cell Lung Cancer with and without Prior Treatment with PD-1/PD-L1 Inhibitors
09:30 - 09:30 | Presenter: Wade Thomas Iams | Author(s): Y.K. Chae, S. Pai, R. Costa, T. Taxter, N. Mohindra, V. Villaflor, B. Pro, F.J. Giles
- Abstract
Loading... -
+
P1.04-006 - Rovalpituzumab Tesirine vs Topotecan in Patients with Advanced Small Cell Lung Cancer Following 1st Line Chemotherapy
09:30 - 09:30 | Presenter: Philip Komarnitsky | Author(s): H. Lee, M. Shah, S. Wong, S. Gulbranson, J. Dziubinski, L. Caffrey, P. Tanwani, M. Motwani, F. Zhang
- Abstract
Loading... -
+
P1.04-007 - Rovalpituzumab Tesirine Maintenance Therapy Following 1st Line Platinum-Based Chemotherapy Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Philip Komarnitsky | Author(s): H. Lee, M. Shah, S. Wong, S. Gauthier, J. Dziubinski, S. Osbaugh, F. Zhang
- Abstract
Loading... -
+
P1.04-008 - POSEIDON: A Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Chemotherapy vs Chemotherapy Alone in Metastatic NSCLC
09:30 - 09:30 | Presenter: Tony SK Mok | Author(s): M.L. Johnson, Edward Brian Garon, Solange Peters, J. Soria, L. Wang, A. Jarkowski, P.A. Dennis, Caicun Zhou
- Abstract
Loading... -
+
P1.04-009 - The First Study of BBSKE in Heavy Treated Advanced EGFR Wild Type and ALK Negative, Trxr1 High Expression NSCLC Patients.
09:30 - 09:30 | Presenter: Yongchang Zhang | Author(s): N. Yang
- Abstract
Loading... -
+
P1.04-010 - CheckMate 870: An Open-label Safety Study of Nivolumab in Previously Treated Patients With Non-Small Cell Lung Cancer in Asia
09:30 - 09:30 | Presenter: Shun Lu | Author(s): Li Zhang, Ying Cheng, Jie Wang, C. Wang, M. Wang, X. Li, Q. Wu, Yi-Long Wu
- Abstract
Loading... -
+
P1.04-011 - Development of Novel Blood-Based Biomarker Assays in 1L Advanced/ Metastatic NSCLC: Blood First Assay Screening Trial (BFAST)
09:30 - 09:30 | Presenter: Tony SK Mok | Author(s): Rafal Dziadziuszko, Solange Peters, X. He, T. Riehl, E. Schleifman, S.M. Paul, S. Mocci, D.S. Shames, M. Mathisen, Shirish M Gadgeel
- Abstract
Loading... -
+
P1.04-012 - A Phase 1b Dose-Escalation Study of TRC105 in Combination with Nivolumab in Patients with Metastatic Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: B. Simpson | Author(s): Francisco Robert, C. Theuer, M.N. Saleh, J. Keef, M. Jerome
- Abstract
Loading... -
+
P1.04-013 - Phase 1b Multi-Indication Study of the Antibody Drug Conjugate Anetumab Ravtansine in Patients with Mesothelin-Expressing Advanced or Recurrent Malignancies
09:30 - 09:30 | Presenter: Alex Adjei | Author(s): A. Walter, L. Cupit, J. Siegel, A. Holynskyj, B.H. Childs, C. Elbi
- Abstract
Loading...
-
+
P1.05 - Early Stage NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Early Stage NSCLC
-
+
- Abstract
Loading... -
+
P1.05-002 - Characteristics and Prognosis of Ground Glass Opacity Predominant Primary Lung Cancer Larger Than 3.0 Cm on Thin-Section Computed Tomography
09:30 - 09:30 | Presenter: Shigeki Suzuki | Author(s): H. Sakurai, K. Masai, Keisuke Asakura, K. Nakagawa, N. Motoi, Shun-ichi Watanabe
- Abstract
Loading... -
+
P1.05-003 - Impact of Coexisting Pulmonary Diseases on Oncological Outcomes of Patients with pStage I Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hiroyuki Tao | Author(s): H. Onoda, M. Hayashi, A. Hara, R. Miyazaki, D. Murakami, M. Furukawa, Kazunori Okabe
- Abstract
Loading... -
+
P1.05-004 - Adenocarcinoma Subtyping of Early Stage Lung Cancer in a Danish Cohort
09:30 - 09:30 | Presenter: Petrine laier Sonne | Author(s): J. Cortsen, H. Hager, K. Ege Olsen, P. Licht
- Abstract
Loading... -
+
P1.05-005 - Percutaneous Cryoablation for Lung Cancer Patients with Idiopathic Pulmonary Fibrosis
09:30 - 09:30 | Presenter: Takashi Ohtsuka | Author(s): K. Masai, Kaoru Kaseda, T. Hishida, S. Nakatsuka, Hisao Asamura
- Abstract
Loading... -
+
P1.05-006 - Clinicopathological Features of Small-Sized Peripheral Squamous Cell Lung Cancer
09:30 - 09:30 | Presenter: Takayuki Kosaka | Author(s): S. Nakazawa, N. Kawatani, K. Obayashi, J. Atsumi, T. Yajima, K. Shimizu, A. Mogi, H. Kuwano
- Abstract
Loading... -
+
P1.05-007 - A Retrospective Study to Compare Resection Rate and Survival Rate in Operable Stage I to III NSCLC After Introduction of Lung Cancer MDT
09:30 - 09:30 | Presenter: Ying Ying Sum | Author(s): C.S. Kan, S.Y. Soon, S. Eunice Ong, K.M. Adeline Lau, P.J. Voon
- Abstract
Loading... -
+
P1.05-008 - A Comparison of the Imaging Features of Early Stage Primary Lung Cancer in Patients Treated with Surgery, SABR and Microwave Ablation
09:30 - 09:30 | Presenter: Ambika Talwar | Author(s): N. Jenko, J. Willaime, S. Ather, W. Hickes, L. Pickup, N. Rahman, Timor Kadir, F. Gleeson
- Abstract
Loading... -
+
P1.05-009 - Analysis of Postoperative Prognosis in Terms of the Difference Between the Invasive Growth Area and the Total Tumor Diameter
09:30 - 09:30 | Presenter: Masaya Yotsukura | Author(s): Yota Suzuki, Kaoru Kaseda, K. Masai, Y. Hayashi, T. Hishida, Takashi Ohtsuka, Hisao Asamura
- Abstract
Loading... -
+
P1.05-010 - Curative Treatment Rates for Patients Diagnosed with Early Stage Non-Small Cell Lung Cancer (NSCLC) in England
09:30 - 09:30 | Presenter: Neal Navani | Author(s): A. Khakwani, S.V. Harden, David Raymond Baldwin, K. Foweraker, R. Dickinson, D. West, P. Beckett, R.B. Hubbard
- Abstract
Loading... -
+
P1.05-011 - Comparison of Tumor Measurement Methods in Patients with Clinical Stage IA Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Takuya Nagashima | Author(s): Hiroyuki Ito, Joji Samejima, Junichiro Osawa, Kenji Inafuku, M. Nito, H. Nakayama, K. Yamada, T. Yokose
- Abstract
Loading... -
+
P1.05-012 - Treatment Planning in Non-Small Cell Lung Cancer Shows Variable Utilization of Multidisciplinary Tumor Board
09:30 - 09:30 | Presenter: Joshua Robert Rayburn | Author(s): Candice Leigh Wilshire, C.R. Gilbert, B.E. Louie, R. Aye, A.S. Farivar, Eric Vallieres, J.A. Gorden
- Abstract
Loading... -
+
P1.05-013 - Induction Chemoradiation Is Associated with Improved Survival in Resected Non-Pancoast Lung Cancer with Chest Wall Invasion
09:30 - 09:30 | Presenter: Kei Suzuki | Author(s): J.A. Munoz-Largacha, S.R. Rao, B. Daly, V.R. Litle
- Abstract
Loading... -
+
P1.05-014 - Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: S.H. Kim | Author(s): Min Kwang Byun, H.J. Park, Heae Surng Park, H. Jeung, J.Y. Cho, S.S. Lee
- Abstract
Loading... -
+
P1.05-015 - Major Pathological Response as a Predictive Value of Survival in Early-Stage NSCLC After Chemotherapy: Cohort of NATCH Phase III Trial
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): A. Martinez, J.L. Mate, J. Sansano, N. Pardo, A. Estival, A. Navarro, A. Martinez De Castro, J. Zeron-Medina, L. Romero Vielva, T. Morán, S. Cedres, Enriqueta Felip
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.05-017 - Prognostic Significance of Preoperative Plasma D-Dimer Level in Patients with Surgically Resected Clinical Stage I Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kaoru Kaseda | Author(s): Keisuke Asakura, A. Kazama, Y. Ozawa
- Abstract
Loading... -
+
P1.05-018 - Prognostic Impact of Tumor Shadow Disappearance Rate in Patients with Clinical IA Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Joji Samejima | Author(s): H. Ito, H. Nakayama, Takuya Nagashima, Junichiro Osawa, Kenji Inafuku, M. Nito, T. Yokose, K. Yamada, M. Masuda
- Abstract
Loading... -
+
P1.05-019 - Effects of Tumor Stroma and Inflammation on Survival of Stage I-IIp Lung Cancer
09:30 - 09:30 | Presenter: Eduard Monsó | Author(s): L. Millares, J. Alcaraz, A. Martinez, I. Benchea, J. Carrasco, J. Sanchez De Cos, M.A. Gonzalez-Castro, A. Blanco, R. Sanchez-Gil, M. Serra, Ramon Rami-Porta, J. Sauleda, E. Fernandez, R. Melchor, L. Seijo, L. De Esteban Julvez, E. Barreiro, C.G.I.L.C. Ciberes-Rticc-Separ-Plataforma Biobanco Pulmonar
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.05-021 - Are Prognostic Factors Different from That Which Predicts Recurrence in Completely Resected Pathological Stage IB Adenocarcinoma?
09:30 - 09:30 | Presenter: Hiroyuki Ito | Author(s): H. Nakayama, Takuya Nagashima, Joji Samejima, Junichiro Osawa, Kenji Inafuku, M. Nito, K. Yamada, T. Yokose
- Abstract
Loading... -
+
P1.05-022 - Association Between Neutrophil/Lymphocyte Ratio and Lymphocyte/Monocyte Ratio with Disease Free Survival in Operated NSCLC Patients in Peru
09:30 - 09:30 | Presenter: Rodrigo Motta | Author(s): D. Castro Uriol, L. Vera
- Abstract
Loading... -
+
- Abstract
No abstract available for this presentation
-
+
P1.05-022b - Identifying Novel Markers of Early Stage Lung Cancer Using a CRISPR/Cas9 Mouse Model
09:30 - 09:30 | Presenter: Paola A Marignani
- Abstract
Loading... -
+
P1.05-022c - Screening for Psychosocial Distress in Lung Cancer: Defining the Unmet Gaps
09:30 - 09:30 | Presenter: Rob Stirling | Author(s): J. Wasiak, A. Earnest, M. Brand, N. Holt, L. Mansfield, H. Mott, J.H. Gooi, J.D. Ruben, M. Moore, M. McInerney, C. Li, S.M. Evans
- Abstract
Loading... -
+
P1.05-022d - Lung Cancer in the Innocent Isn't so Innocent
09:30 - 09:30 | Presenter: Sudish Murthy | Author(s): U. Ahmad, S. Raja, C. Bariana, D. Raymond, Vamsidhar Velcheti, P. Mazzone, E. Blackstone
- Abstract
Loading...
-
+
P1.06 - Epidemiology/Primary Prevention/Tobacco Control and Cessation
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
-
+
P1.06-001 - Does Access to Private Health Care Influence Potential Lung Cancer Cure Rates?
09:30 - 09:30 | Presenter: Thadathilankal Jess John | Author(s): D. Plekker, E. Irusen, C. Koegelenberg
- Abstract
Loading... -
+
P1.06-002 - The Role of Comorbidity in the Management and Prognosis in Nonsmall Cell Lung Cancer: A Population-Based Study
09:30 - 09:30 | Presenter: Jonas Nilsson | Author(s): A. Berglund, S. Bergström, M. Bergqvist, M. Lambe
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.06-004 - Occurrence of Lung Cancer among Young Patients Below the Age of 50 – A Retrospective Analysis
09:30 - 09:30 | Presenter: Anna Maria Romaszko-Wojtowicz | Author(s): K. Mogielnicka, K. Późniewska, A. Doboszyńska
- Abstract
Loading... -
+
P1.06-005 - Sex-Based Disparities in NSCLC: An Evidence-Based Study
09:30 - 09:30 | Presenter: Noor Asaad Alsaadoun | Author(s): K. Kopciuk, D. Hao, K. Riabowol, M. Hollenberg, D. Gwyn Bebb
- Abstract
Loading... -
+
P1.06-006 - Survival Benefits and Associated Prognostic Factors among Young NSCLC Patients
09:30 - 09:30 | Presenter: Gwyn Bebb | Author(s): A. D'Silva, R.A. Tudor, A.A. Elegbede, A.J.W. Gibson, S. Otsuka, H. Li, W. Cheung
- Abstract
Loading... -
+
P1.06-007 - EGFR Status Evaluation and Epidemiological Profile in Patients with NSCLC in a Brazilian Public Health Instituition
09:30 - 09:30 | Presenter: Carolina Dutra | Author(s): C.D.S.M. Emerich, M. Debiasi, F.Z. Caorsi, S.E. Beal, T.C.M. Flores
- Abstract
Loading... -
+
P1.06-008 - Prevalence of Lung Cancer in Patients with Interstitial Lung Disease is Higher than in those with Chronic Obstructive Pulmonary Disease
09:30 - 09:30 | Presenter: Wonil Choi
- Abstract
Loading... -
+
P1.06-009 - Barriers to Clinical Trial Participation in Lung Cancer Patients, a Single Institution Experience
09:30 - 09:30 | Presenter: Christina S Baik | Author(s): C.L. Geiger, K. Baker, Mary Redman, B. Goulart, K.D. Eaton, R.G. Martins
- Abstract
Loading... -
+
P1.06-010 - Interaction between Treatment Delivery Delay and Stage on the Mortality from Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Fernando Conrado Abrão | Author(s): R. Rocha, I. Abreu, J. Rodrigues, F. Munhoz, B. Batista
- Abstract
Loading... -
+
P1.06-011 - Hyponatremia - Evaluation of Prevalence in Hospitalized Lung Cancer Patients and Its Prognostic Significance
09:30 - 09:30 | Presenter: Sharif Ahmed | Author(s): M.M. Hassan
- Abstract
Loading... -
+
P1.06-012 - Non-Small Cell Lung Cancer (NSCLC) Patient Characteristics and Clinical Care Insights in Sweden: The SCAN-LEAF Study
09:30 - 09:30 | Presenter: Martin Sandelin | Author(s): M. Planck, J.B. Sørensen, O.T. Brustugun, J. Rockberg, A. Juarez-Garcia, D. Layton, M. Manley Daumont, H. Huang, M. Pereira, J. Svärd, M. Rosenlund, Oana Chirita, L. Jørgensen, Simon Ekman
- Abstract
Loading... -
+
P1.06-013 - Latent Tuberculosis in Newly Diagnosed Lung Cancer Patients. An Spanish Prospective Study
09:30 - 09:30 | Presenter: Ruth Alvarez Cabellos | Author(s): E. Martinez Moreno, C. Esteban Esteban, A. Irigoyen, E. Muñoz Platón, J. Andrade Santiago, I. Burgueño Lorenzo, J.D. Cardenas, K. Martinez Barroso, A.K. Santos, M. Borregon Rivilla, B. Trujillo Alba, J.I. Chacon Lopez-Muñiz
- Abstract
Loading... -
+
P1.06-014 - Higher Body Mass Index Prolongs Survival Time in Non-Small Cell Lung Cancer with Good Performance Status
09:30 - 09:30 | Presenter: Tomohiro Suzumura | Author(s): Tomoya Kawaguchi, S. Mitsuoka, Tatsuo Kimura, Naruo Yoshimura, N. Yoshimoto, K. Sawa, Y. Matsumoto, K. Hirata
- Abstract
Loading... -
+
P1.06-015 - Analysis of Relationship Between Non-Small Cell Lung Cancer and Nicotine Dependence
09:30 - 09:30 | Presenter: Yoon Ho Ko | Author(s): C.D. Yeo, K. Ju Sang, S.H. Lee, S.J. Kim, S. Paik, D. Kim
- Abstract
Loading... -
+
P1.06-016 - Route to Lung Cancer Diagnosis in the UK: How Does This Affect Patient Outcome?
09:30 - 09:30 | Presenter: Sher May Ng | Author(s): J. Pan, S. Gareeboo
- Abstract
Loading... -
+
P1.06-017 - Lung Cancer Detection Rates for National Comprehensive Cancer Network Group 2 High Risk Individuals
09:30 - 09:30 | Presenter: Andrea Katalin Borondy Kitts | Author(s): S.M. Regis, K.M. Reiger-Christ, J.M. Sands, A.B. McKee, S. Flacke, B.J. McKee
- Abstract
Loading... -
+
P1.06-018 - EGFR Mutations and ALK Gene Rearrangements: Changing Patterns of Molecular Testing in Brazil
09:30 - 09:30 | Presenter: Gilberto Lopes | Author(s): S. Palacio, R. Mudad, E. Prado
- Abstract
Loading... -
+
P1.06-019 - The Association Between HPV Presence and EGFR Mutations in Asian Patients with NSCLC: A Meta-Analysis
09:30 - 09:30 | Presenter: Hengrui Liang | Author(s): Y. Chen, J. He, Wenhua Liang
- Abstract
Loading... -
+
P1.06-020 - Unequal Access to Health Care System Have a Higher Impact in Upgrading Staging for 8th TNM Ed
09:30 - 09:30 | Presenter: Maria Teresa Ruiz Tsukazan | Author(s): A. Vigo, L. Lago, G. Lenz, V. Duval Da Silva, J. Figueiredo Pinto, J. Rios, M.H. Sostruznik
- Abstract
Loading... -
+
P1.06-021 - Lung Cancer Among Women Assisted in an Argentinean University Institution
09:30 - 09:30 | Presenter: Carolina Gabay | Author(s): I. Boyeras, M. Bonet, L.A. Thompson, M.A. Castro
- Abstract
Loading... -
+
P1.06-022 - Prognostic Value of NLR in Overall Survival of Patients with Advanced Lung Cancer
09:30 - 09:30 | Presenter: Claudio Flores | Author(s): A. Aguilar, L.A. Mas Lopez, Jose Maria Gutierrez Castañeda, R. Ruiz Mendoza, L. Pinillos-Ashton, C. Vallejos
- Abstract
Loading... -
+
P1.06-023 - Spatio-Temporal Distribution of Lung Cancer Mortality Rate in Peru: 2005-2014
09:30 - 09:30 | Presenter: Claudio J. Flores | Author(s): J.S. Torres-Roman, L.A. Mas Lopez, R. Ruiz Mendoza, C.A. Samanez, A. Aguilar, C. Vallejos
- Abstract
Loading... -
+
P1.06-024 - Outcome of Non-Small Cell Lung Cancer Patients Treated in the Private Health Care in Brazil
09:30 - 09:30 | Presenter: Luiz H. Araujo | Author(s): Clarissa Baldotto, M. Batista, F. Lemos, M. Padoan, N. Carvalho, P. Andrade, M. Zukin, N. Teich
- Abstract
Loading...
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P1.07-001 - Clinical Value of Expression of PD-L1 and CD8 of 58 Cases with NSCLC
09:30 - 09:30 | Presenter: Hongnian Wu | Author(s): Q. Zhang
- Abstract
Loading... -
+
P1.07-002 - The Expression of PD-L1 Protein as a Prognostic Factor in Lung Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Kazuki Takada | Author(s): Tatsuro Okamoto, Gouji Toyokawa, Yuka Kozuma, T. Matsubara, Naoki Haratake, Takaki Akamine, Shinkichi Takamori, M. Katsura, Fumihiro Shoji, Y. Oda, Y. Maehara
- Abstract
Loading... -
+
P1.07-003 - Cytolitic Tests with Hyperimmune Patient Sera Is a Good Prognostic Tool in Racotumomab Immunotherapy in Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Necdet Ismail Hakk? Uskent
- Abstract
Loading... -
+
P1.07-004 - Predictive Biomarkers of Response to Nivolumab in Non–Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study
09:30 - 09:30 | Presenter: Yuki Kataoka | Author(s): K. Hirano, T. Narabayashi, S. Hara, D. Fujimoto, T. Tanaka, N. Ebi, K. Tomii, H. Yoshioka
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.07-007 - Interleukin-17A Promotes Lung Tumor Progression Through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.
09:30 - 09:30 | Presenter: Esra A Akbay | Author(s): S. Koyama, G. Dranoff, Kwok-Kin Wong
- Abstract
Loading... -
+
P1.07-008 - Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors
09:30 - 09:30 | Presenter: Jonathan R Thompson | Author(s): A. Szabo, C. Arce-Lara, S. Menon
- Abstract
Loading... -
+
P1.07-009 - PD-L1 Expression in Circulating Tumor Cells and Response to PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Nicolas Guibert | Author(s): M. Delaunay, N. Boubekeur, I. Rouquette, A. Lusque, E. Clermont, A. Fortoul, M. Farella, G. Favre, A. Pradines, Julien Mazieres
- Abstract
Loading... -
+
P1.07-010 - Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
09:30 - 09:30 | Presenter: Junko Tanizaki | Author(s): K. Haratani, Hidetoshi Hayashi, Y. Chiba, Kimio Yonesaka, K. Kudo, H. Kaneda, Y. Hasegawa, K. Tanaka, M. Takeda, Kazuhiko Nakagawa
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.07-012 - Prediction Sensitivity of PD-1 Checkpoint Blockade Using Pathological Tissues Specimens by Novel Computerized Analysis System
09:30 - 09:30 | Presenter: Akira Saito | Author(s): N. Aramaki, Y. Makino, J. Matsubayashi, T. Ohira, Norihiko Ikeda, M. Kuroda
- Abstract
Loading... -
+
P1.07-013 - Detection of Genomic Alterations in Plasma Circulating Tumor DNA in Patients with Metabolically Active Lung Cancers
09:30 - 09:30 | Presenter: Tianhong Li | Author(s): Z. Yuan, C. Zhou, L. Qi, A. Mahavongtrakul, Y. Li, D. Yan, Y. Rong, W. Ma, J. Gong, J. Li, M. Molmen, T.A. Clark, G.M. Frampton, M. Cooke, E.H. Moore, D.K. Shelton, R.D. Badawi, J.P. Gregg, P.J. Stephens
- Abstract
Loading... -
+
P1.07-014 - Association of Preoperative Serum CRP with PD-L1 Expression in NSCLC: A Comprehensive Analysis of Systemic Inflammatory Markers
09:30 - 09:30 | Presenter: Takaki Akamine | Author(s): Kazuki Takada, Gouji Toyokawa, F. Kinoshita, T. Matsubara, Yuka Kozuma, Naoki Haratake, Shinkichi Takamori, F. Hirai, T. Tagawa, Tatsuro Okamoto, Y. Yoneshima, Isamu Okamoto, M. Shimokawa, Y. Oda, Yoichi Nakanishi, Y. Maehara
- Abstract
Loading... -
+
P1.07-015 - Interferon-Gamma (INFG) as a Biomarker to Guide Immune Checkpoint Blockade (ICB) in Cancer Therapy
09:30 - 09:30 | Presenter: Niki Karachaliou | Author(s): M. González Cao, A. Giménez-Capitán, A. Drozdowskyj, E. Aldeguer, C. Teixido, G. Crespo, Miguel-Angel Molina-Vila, S. Viteri, M. De Los Llanos Gil, S. Martín Algarra, E. Pérez-Ruiz, I. Márquez-Rodas, D. Rodríguez-Abreu, R. Blanco, T. Puértolas, M.A. Royo, Rafael Rosell
- Abstract
Loading... -
+
P1.07-016 - Comparison of PD-L1 Immunohistochemical Staining between EBUS-TBNA and Resected Non-Small Cell Lung Cancer Specimens
09:30 - 09:30 | Presenter: Kenneth Kazuto Sakata | Author(s): D. Midthun, J.J. Mullon, R.M. Kern, D.R. Nelson, E. Edell, Jim Jett, M.C. Aubry
- Abstract
Loading... -
+
P1.07-017 - Assessment of Cancer Immunity Status in Each Patient Using Immunogram
09:30 - 09:30 | Presenter: Takahiro Karasaki | Author(s): K. Nagayama, K. Fukumoto, K. Kitano, J. Nitadori, M. Sato, M. Anraku, A. Hosoi, H. Matsushita, K. Kakimi, Jun Nakajima
- Abstract
Loading... -
+
P1.07-018 - A Meta-Analysis of PD-L1 Expression as a Biomarker of PD-1 Blockade in Advanced Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Johnathan Man | Author(s): V. Gebski, A. Mulvey, R. Hui
- Abstract
Loading... -
+
P1.07-019 - Immune Cell Infiltrates in Non-Small Cell Lung Cancer and Interleukin-22 Expression
09:30 - 09:30 | Presenter: Rudolf M Huber | Author(s): J. Stump, S. Reu, C. Ballesteros-Merino, C. Karches, J.S. Gosálvez, A. Tufman, S. Kobold, J. Neumann, Z. Feng, R. Hatz, R.E. Sanborn, John R Handy, B.A. Fox, C.B. Bifulco, H. Winter
- Abstract
Loading... -
+
P1.07-020 - Autoantibody Profiles of Cancer-Testis Genes in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Dijana Djureinovic | Author(s): C. Hellström, T. Dodig-Crnkovic, F. Ponten, M. Bergqvist, Georg Holgersson, J.M. Schwenk, Patrick Micke
- Abstract
Loading... -
+
P1.07-021 - Multiplex Immune Profiling Identifies Prognostic Importance of the Spatial Co-Localization of Immune Cells in NSCLC
09:30 - 09:30 | Presenter: Artur Mezheyeuski | Author(s): C. Bergsland, M.W. Backman, T. Sjöblom, R.A. Lothe, J. Bruun, Patrick Micke
- Abstract
Loading... -
+
P1.07-022 - Routine PD-L1 Immunohistochemistry Testing by 22C3 in a Canadian Reference Testing Centre
09:30 - 09:30 | Presenter: Ming Sound Tsao | Author(s): T. Albaqer, R.C. Santiago, Y. Leung, P. Pal, Z. Khan, E. Torlakovic, C. Cheung, D.M. Hwang
- Abstract
Loading... -
+
P1.07-023 - The Correlation Between B7-H4 Expression and Survival of Non-Small Cell Lung Cancer Patients Treated with Nivolumab
09:30 - 09:30 | Presenter: Francesco Grossi | Author(s): C. Genova, S. Boccardo, P. Bruzzi, M. Mora, E. Rijavec, G. Rossi, F. Biello, G. Barletta, M. Tagliamento, M.G. Dal Bello, A. Alama, S. Coco, I. Vanni
- Abstract
Loading... -
+
P1.07-024 - ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD-1/PD-L1 Inhibitors but
Not Chemotherapies or Targeted Kinase Inhibitors09:30 - 09:30 | Presenter: Wungki Park | Author(s): D. Kwon, A. Desai, V. Florou, D. Saravia, J. Warsch, Young Kwang Chae, A. Ishkanian, M. Jahanzeb, R. Mudad, Gilberto Lopes
- Abstract
Loading... -
+
P1.07-025 - Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab
09:30 - 09:30 | Presenter: Wungki Park | Author(s): Gilberto Lopes, D. Kwon, V. Florou, Young Kwang Chae, J. Warsch, A. Ishkanian, M. Jahanzeb, R. Mudad
- Abstract
Loading... -
+
P1.07-026 - Predicting Tumor Mutational Burden (TMB) and Tumor Neoantigen Burden (TNB) of East Asian ANSCLC Patients by a Targeted Genomic Profiling
09:30 - 09:30 | Presenter: Likun Chen
- Abstract
Loading... -
+
P1.07-027 - PD-L1 Expression Analysis in African American (AA) and Hispanic Lung Cancer Patients at a Minority-Based Academic Cancer Center
09:30 - 09:30 | Presenter: Elaine Shum | Author(s): C. Su, C. Zhu, R.A. Gucalp, M. Haigentz Jr., S.H. Packer, R. Perez-Soler, Balazs Halmos, Haiying Cheng
- Abstract
Loading... -
+
P1.07-028 - Determination of Soluble PD-L1 as a Potential Biomaker for Anti-PD(L)1 Therapy in Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Margarita Majem Tarruella | Author(s): A. Barba Joaquín, C. Zamora Atenza, S. Vidal Alcorisa, I.G. Sullivan, G. Anguera Palacios, M.A. Ortiz De Juana, M. Andrés Granyò, A.C. Virgili Manrique, N. Dueñas Cid, A.C. Vethencourt Casado, L.P. Del Carpio Huerta, P. Gomila Pons, S.D. Camacho Arellano, S. Moron Asensio, M. Riudavets Melia, C. Molto Valiente, A. Callejo Perez
- Abstract
Loading... -
+
P1.07-029 - Correlation Study Between Plasma sPD-L1 and the Efficacy and Prognosis of Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Xiaoyan Kang | Author(s): X. Song
- Abstract
Loading... -
+
P1.07-030 - Prognostic Impact of PD-L1 Expression in Correlation with HLA Class I Expression Status in Adenocarcinoma of the Lung
09:30 - 09:30 | Presenter: Kazue Yoneda | Author(s): A. Hirai, S. Shimajiri, K. Kuroda, T. Hangiri, Fumihiro Tanaka
- Abstract
Loading... -
+
P1.07-031 - Autoantibodies Associated with Risk of Subclinical Autoimmunity and Immune-Related Adverse Events from Checkpoint Inhibitor Therapy
09:30 - 09:30 | Presenter: David E Gerber | Author(s): S. Khan, Q.Z. Li, L. Feng, F. Fattah, S. Khan, J. Saltarski, Y.G. McCuthchen, X. Luo, Y. Xie, W. Wakeland
- Abstract
Loading... -
+
P1.07-032 - 28-Color, 30 Parameter Flow Cytometry to Dissect the Complex Heterogeneity of Tumor Infiltrating T Cells in Lung Cancer
09:30 - 09:30 | Presenter: Pierluigi Novellis | Author(s): J. Brummelman, F. De Paoli, A. Anselmo, Giulia Veronesi, M. Alloisio, E. Lugli
- Abstract
Loading... -
+
P1.07-033 - Differential Expression of Immune Inhibitory Markers in Association with the Immune Microenvironment in Resected Lung Adenocarcinomas
09:30 - 09:30 | Presenter: Mingjuan Lisa Zhang | Author(s): M. Kem, M.J. Mooradian, J. Eliane, T. Huynh, A.J. Iafrate, Justin F Gainor, Mari Mino-Kenudson
- Abstract
Loading... -
+
P1.07-034 - Pretreatment Neutrophil & Platelet Count as a Predictor for Unfavorable Clinical Outcome in Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Sarita Agte | Author(s): Y.K. Chae, A.A. Davis, A. Pan, N.A. Mohindra, V. Villaflor
- Abstract
Loading... -
+
P1.07-035 - Lymphocytes and Neutrophils Count After Two Cycles and TTF1 Expression as Early Outcome Predictors During Immunotherapy
09:30 - 09:30 | Presenter: Iosune Baraibar | Author(s): Marta Roman Moreno, E. Castañón, M.Á. García Del Barrio, Christian Rolfo, J.M. López-Picazo, J.L. Perez-Gracia, A. Gúrpide, Ignacio Gil-Bazo
- Abstract
Loading... -
+
P1.07-036 - LC-HRMS Metabolomics Profiling in Advanced NSCLC Treated with Anti PD-1 Agents. Metabolic Features at Diagnosis and at Response Evaluation
09:30 - 09:30 | Presenter: Ana Laura Ortega Granados | Author(s): F.J. García Verdejo, N. Cárdenas Quesada, M. Ruiz Sanjuan, C. Díaz Navarro, C. De La Torre Cabrera, M. Fernández Navarro, G. Pérez Chica, F. Vicente Pérez, M.Á. Moreno Jiménez, N. Luque Caro, B. Márquez Lobo, A. Jaén Morago, R. Dueñas García, E. Martínez Ortega, P. Sánchez Rovira, J. Pérez Del Palacio
- Abstract
Loading... -
+
P1.07-037 - Testing the Positive and Negative Immune Checkpoint on PBMCs of Patients from Initiatory to Terminative Treatment of Anti PD-1 Antibody
09:30 - 09:30 | Presenter: Wushuang Du | Author(s): Y. Hu
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.07-039 - Blood Biomarkers Correlate with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti PD-1 Antibodies
09:30 - 09:30 | Presenter: Yanyan Lou | Author(s): A.E. Soyano, Bhagirathbhai Dholaria, J. Marin, N. Diehl, D. Hodge, Y. Luo, L. Yang, Alex Adjei, K. Knutson
- Abstract
Loading... -
+
P1.07-040 - Prognosis-Relevant Subgroups in NSCLC According to Granulocytic Myeloid-Derived Suppressor Cell Frequency and Cytokine Levels
09:30 - 09:30 | Presenter: Oscar Arrieta | Author(s): Lourdes Barrera, E. Montes-Servin, J.M. Hernandez Martinez, M. Orozco Morales, E. Montes Servin
- Abstract
Loading... -
+
P1.07-041 - CD47 Expression and Prognosis in a Cohort of Patients with Lung Adenocarcinoma (NSCLC)
09:30 - 09:30 | Presenter: Oscar Arrieta | Author(s): M. Orozco-Morales, Andrés F. Cardona, A. Avilés, Norma Yanet Hernandez-Pedro, L. Cabrera-Miranda, G. Soca-Chafre, P. Barrios, G. Cruz-Rico
- Abstract
Loading... -
+
P1.07-042 - PD-L1 and CD8 Expression in EGFR-Mutant or ALK-Rearranged Patients with Lung Cancer
09:30 - 09:30 | Presenter: Yi-Long Wu | Author(s): S. Liu, Z. Dong, S. Wu, Z. Xie, J. Su, Jin -Ji Yang, X. Yang
- Abstract
Loading... -
+
P1.07-043 - Barrier Molecule Overexpression is Associated with Increased CD8 T Cells and Decreased B/Treg Cells in Human Lung Cancer
09:30 - 09:30 | Presenter: Wooyoung Monica Choi | Author(s): Young Kwang Chae, W.H. Bae, J. Anker, A.A. Davis, Wade Thomas Iams, M. Cruz, M. Matsangou, F.J. Giles
- Abstract
Loading... -
+
P1.07-044 - The Impact of Neutrophil/Lymphocyte Ratio as the Predictive Marker to Anti-PD-1 Antibody Treatment in NSCLC Patients
09:30 - 09:30 | Presenter: Keiko Tanimura | Author(s): T. Yamada, N. Tamiya, Y. Kaneko, J. Uchino, K. Takayama
- Abstract
Loading... -
+
P1.07-044a - Comparison of Tumor Mutational Burden (TMB) Derived from Whole Exome and Large Panel Sequencing in Lung Cancer
09:30 - 09:30 | Presenter: Gang Cheng | Author(s): G. Shan, L. Zhao, L. Li, B. Liu
- Abstract
No abstract available for this presentation
-
+
P1.07-044b - Pretreatment Neutrophil/Lymphocyte Ratio and the Efficacy of Nivolumab Treatment in Non–Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Hiroshi Kobayashi | Author(s): Kazutoshi Isobe, T. Yoshizawa, K. Kaburaki, K. Gocho, K. Sugino, S. Sakamoto, Y. Takai, N. Tochigi, S. Homma
- Abstract
Loading... -
+
P1.07-044c - Neurological Complications Following Treatment with Anti-PD1 Immune Checkpoint Inhibitors
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): R. Mason, R. Caldwell, P. Inglis, V. Andelkovic, M. McGrath, E. McCaffrey
- Abstract
Loading... -
+
P1.07-044d - Positive Conversion of the PD-L1 Expression after Treatments with Chemotherapy and Nivolumab
09:30 - 09:30 | Presenter: Naoki Haratake | Author(s): Gouji Toyokawa, T. Tagawa, T. Matsubara, Yuka Kozuma, Takaki Akamine, Shinkichi Takamori, Y. Maehara
- Abstract
Loading...
-
+
P1.08 - Locally Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Locally Advanced NSCLC
-
+
P1.08-001 - Surgical versus Non-Surgical Treatments for Resectable Stage III NSCLC: A Systematic Review and Meta-Analysis
09:30 - 09:30 | Presenter: Wee Yao Koh | Author(s): Y.Y. Soon, C.N. Leong, Ivan WK Tham
- Abstract
Loading... -
+
P1.08-002 - Blood Supply to the Tumor Do Not Predict the Effect of Induction Therapy in Patients with Locally Advanced Lung Cancer
09:30 - 09:30 | Presenter: Koji Kawaguchi | Author(s): T. Fukui, Shota Nakamura, S. Hakiri, N. Ozeki, T. Kato, K. Yokoi
- Abstract
Loading... -
+
P1.08-003 - Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable, Stage III Non-Small Cell Lung Cancer: A Phase I Study
09:30 - 09:30 | Presenter: Kristin A Higgins | Author(s): Rathi N Pillai, Z. Chen, C. Zhang, P. Patel, S. Pakkala, J. Shelton, S. Force, F. Fernandez, C. Steuer, Taofeek K Owonikoko, Suresh S Ramalingam, Jeffrey Bradley, Walter John Curran, Jr.
- Abstract
Loading... -
+
P1.08-004 - Adjuvant Chemoradiotherapy vs. Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Jong-Mu Sun | Author(s): Hong Kwan Kim, S. Lee, Yong Chan Ahn, Jhingook Kim, Myung-Ju Ahn, J.I. Zo, Y.M. Shim, Keunchil Park
- Abstract
Loading... -
+
P1.08-005 - Preoperative Analysis of 18FDG-PET Features May Predict Loco-Regional Invasiveness in NSCLC
09:30 - 09:30 | Presenter: Pietro Bertoglio | Author(s): A. Viti, M. Salgarello, S. Pasetto, G.S. Bogina, A.C. Terzi
- Abstract
Loading... -
+
P1.08-006 - Phase I/II Study of Carboplatin, nab-paclitaxel, and Concurrent Radiation Therapy for Patients with Locally Advanced NSCLC.
09:30 - 09:30 | Presenter: Yuko Kawano | Author(s): H. Yamaguchi, K. Hirano, A. Horiike, Miyako Satouchi, Shinobu Hosokawa, R. Morinaga, Kazutoshi Komiya, K. Inoue, Y. Fujita, M. Takenoyama, Tomoki Kimura, M. Okuno, Y. Hisamatsu, J. Kishimoto, T. Sasaki, Yoichi Nakanishi, Isamu Okamoto
- Abstract
Loading... -
+
P1.08-007 - Surgery versus Concurrent Chemoradiotherapy for Resectable CIIIA-N2 NSCLC: A Propensity Score Matched Analysis
09:30 - 09:30 | Presenter: Xin Sun | Author(s): Jingjing Kang, Z. Hui
- Abstract
Loading... -
+
P1.08-008 - Chemoradiotherapy in the Regime of Accelerated Fractionation in the Treatment of Lung Cancer
09:30 - 09:30 | Presenter: Yury Ragulin | Author(s): D. Gogolin, I. Gulidov, K. Medvedeva, Y. Mardynsky, I. Ivanova
- Abstract
Loading... -
+
P1.08-009 - Neutrophilia as Prognostic Biomarker in Locally Advanced Stage III Lung Cancer
09:30 - 09:30 | Presenter: Angela Botticella | Author(s): A. Schernberg, Laura Mezquita, A. Boros, C. Caramella, Benjamin Besse, A. Escande, David Planchard, Cecile Le Pechoux, E. Deutsch
- Abstract
Loading... -
+
P1.08-010 - Unsuspected N2 Disease in Patients Undergoing Surgery for Non-Small Cell Lung Cancer: Role of Extent and Location of the Lymph Node Metastasis
09:30 - 09:30 | Presenter: Saana Andersson | Author(s): I. Ilonen, V. Rauma, J. Salo, J. Räsänen
- Abstract
Loading...
-
+
P1.09 - Mesothelioma
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P1.09-001 - Multiplexed Biomarker Strategies Based on Targeted Proteomics for Detection of Malignant Pleural Mesothelioma in Blood
09:30 - 09:30 | Presenter: Ferdinando Cerciello | Author(s): M. Choi, K. Lome, J.M. Amann, E. Felley-Bosco, Rolf A Stahel, B. Robinson, J. Creaney, Harvey I Pass, O. Vitek, David P Carbone
- Abstract
Loading... -
+
P1.09-002 - Cellular Noise and Positional Effects Determine the Cell Stem State in Malignant Mesothelioma
09:30 - 09:30 | Presenter: Walter Blum | Author(s): D. Jean, B. Schwaller, L. Pecze
- Abstract
Loading... -
+
P1.09-003 - Malignant Mesothelioma Versus Synovial Sarcoma: An Analysis of 19 Cases with Molecular Diagnosis
09:30 - 09:30 | Presenter: Sonja Klebe | Author(s): S. Prabhakaran, Ashleigh Jean Hocking, P. Allen, D. Henderson
- Abstract
Loading... -
+
P1.09-004 - YB-1 Suppresses miR-137 via a Feed Forward Loop, Increasing YB-1 Levels, Migration and Invasion in Malignant Mesothelioma
09:30 - 09:30 | Presenter: Karin Schelch | Author(s): Thomas George Johnson, K.H. Sarun, A. Lasham, Nico Van Zandwijk, Glen Reid
- Abstract
Loading... -
+
P1.09-005 - Targeting YB-1 Induces Either Drug Sensitisation or Resistance via Distinct Mechanisms in Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Thomas George Johnson | Author(s): Karin Schelch, K.H. Sarun, A. Lasham, Nico Van Zandwijk, Glen Reid
- Abstract
Loading... -
+
P1.09-006 - JMJ and BRD Domain Family Members in Malignant Pleural Mesothelioma: Potential Therapeutic Targets or Not?
09:30 - 09:30 | Presenter: Steven G. Gray | Author(s): M. Breslin, S. Cregan, L. Quinn, S. Wennstedt, A.S. Singh, L. Macdonagh, G. Roche, Y. Gao, C. Albadri, K. Griggs, Michaela B Kirschner, Kenneth Obyrne, Sonja Klebe, Glen Reid, Stephen P Finn, S. Cuffe
- Abstract
Loading... -
+
P1.09-007 - Targeting MET/TAM Receptors in Mesothelioma: Are Multi-TKIs Superior to Specific TKI?
09:30 - 09:30 | Presenter: Steven G. Gray | Author(s): Anne-Marie Baird, D. Easty, M. Jarzabek, L. Shiels, C. Wu, A. Soltermann, S. Raeppel, L. Macdonagh, M. Melovic, H. Lambkin, B. Stanfill, D. Nonaka, C.M. Goparju, B. Murer, D.M. O'Donnell, L. Mutti, Martin P Barr, Stephen P Finn, S. Cuffe, Harvey I Pass, Kenneth Obyrne, I. Schmitt-Opitz, A.T. Byrne
- Abstract
Loading... -
+
P1.09-008 - A 4-microRNA Signature in Serum Can Discriminate Between Non-Small-Cell Lung Cancer and Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Michaela B Kirschner | Author(s): C. Leygo, S. Burgers, T. Korse, D. Van Den Broek, Nico Van Zandwijk, Glen Reid
- Abstract
Loading... -
+
P1.09-009 - Evaluation of a Combined MicroRNA-Clinical Score as Prognostic Factor for Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Michaela B Kirschner | Author(s): B. Vrugt, M. Friess, M. Meerang, P. Wild, Nico Van Zandwijk, Glen Reid, Walter Weder, I. Opitz
- Abstract
Loading... -
+
P1.09-010 - PD-L1 Reactivity of Tumor Cells Can Successfully Be Determined in Malignant Mesothelioma Effusions
09:30 - 09:30 | Presenter: Annika Dejmek | Author(s): M. Mansour, T. Seidal, U. Mager, A. Baigi, K. Dobra
- Abstract
Loading... -
+
P1.09-011 - LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients with Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Anne Tsao | Author(s): N. Vogelzang, Anna Nowak, Sanjay Popat, R.M. Gaafar, J.P. Van Meerbeeck, T. Nakano, J. Barrueco, N. Morsli, Giorgio Vittorio Scagliotti
- Abstract
Loading... -
+
P1.09-012 - A Pre-Clinical Investigation of Intrapleural Curcumin Treatments as an Adjunct Therapy for Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Ashleigh Jean Hocking | Author(s): D. Elliot, J. Hua, M. Michael, S. Marri, Sonja Klebe
- Abstract
Loading... -
+
P1.09-013 - Profiling Response to Chemotherapy in Malignant Pleural Mesothelioma Among Hispanics (MeSO-CLICaP)
09:30 - 09:30 | Presenter: Andrés F. Cardona | Author(s): Oscar Arrieta, L. Rojas, L. Corrales, B. Wills, G. Oblitas, L. Bacon, Claudio Martin, M. Cuello, L. Mas, C. Vargas, H. Carranza, J. Otero, M.A. Pérez, L. González, L. Chirinos, Rafael Rosell
- Abstract
Loading...